{"study_id": 192639, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Lactobacillus reuteri on digestive health and wellbeing in older adults.", "results_summary": "The study found no persistent significant effects on gastrointestinal symptoms, wellbeing, stress, or anxiety, though a modest reduction in stress was observed at weeks 8 and 12 in the probiotic arm. Some temporary improvements in anxiety were noted at week 8 for subjects with indigestion or abdominal pain, but these effects were not sustained by week 12.", "population_specificity": "Older adults (>65 years)", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:44.412101+00:00"}
{"study_id": 192640, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether Lactobacillus reuteri DSM 17938 is beneficial in reducing functional abdominal pain (FAP) in children.", "results_summary": "Lactobacillus reuteri significantly reduced both the frequency and intensity of abdominal pain compared to placebo after 4 weeks of supplementation, with no significant differences in school absenteeism or other gastrointestinal symptoms except for lower perceived abdominal distention and bloating.", "population_specificity": "Children aged 6-15 years meeting Rome III criteria for functional abdominal pain.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 weeks of intervention, with an additional 4 weeks of follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:44.554603+00:00"}
{"study_id": 192642, "supplement_id": 1275, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To evaluate whether clinical data support the safety and efficacy of probiotics, specifically Lactobacillus reuteri, for managing infantile colic.", "results_summary": "Infants receiving Lactobacillus reuteri had a 2.3-fold greater chance of a 50% or greater reduction in crying/fussing time compared to controls, with no reported adverse events. The probiotic was deemed safe and effective for breastfed infants with colic.", "population_specificity": "Mostly breastfed infants with infantile colic.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:45.071725+00:00"}
{"study_id": 192644, "supplement_id": 1275, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of Lactobacillus reuteri DSM 17938 on feed tolerance, NEC prevention, and other clinical outcomes in preterm neonates.", "results_summary": "The study found that L. reuteri supplementation reduced the time to full feeds, duration of hospitalization, and incidence of late-onset sepsis, with potential but statistically insignificant reductions in mortality and NEC. No adverse effects were reported.", "population_specificity": "Preterm neonates", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:45.245511+00:00"}
{"study_id": 192643, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the anti-Helicobacter pylori (HP) activity of Lactobacillus Reuteri, both as monotherapy and as an adjunct to eradication therapy.", "results_summary": "L. Reuteri produces antimicrobial compounds (e.g., reuterin, reutericyclin) that inhibit HP growth, reduce adhesion to gastric cells, and decrease mucosal inflammation. It shows promise in reducing HP contamination and enhancing eradication therapy effectiveness.", "population_specificity": "Patients with HP infection, including those without absolute indications for eradication therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:45.577440+00:00"}
{"study_id": 192641, "supplement_id": 1275, "safety_score": "100", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily ingestion of Lactobacillus reuteri strains DSM 17938 and ATCC PTA 5289 affects salivary secretory IgA (sIgA) and cytokine levels in healthy young adults.", "results_summary": "The study found no significant differences in salivary sIgA or cytokine levels between the L. reuteri and placebo groups, indicating no detectable effect on the salivary oral immune response in healthy young adults. No adverse effects were reported.", "population_specificity": "Healthy young adults aged 18-32 years.", "effective_dosage": "Two lozenges per day, each containing two strains of L. reuteri.", "study_duration": "3 weeks of intervention, with a 3-week wash-out period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:45.727373+00:00"}
{"study_id": 192645, "supplement_id": 1275, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lactobacillus reuteri DSM 17938 and PTA 5289 consumption alters oral microbiota composition and biofilm formation.", "results_summary": "L. reuteri intake induced a shift in oral microbiota composition, increasing some species (e.g., S. oralis group) and reducing others (e.g., S. mutans), but did not affect species richness. The effect disappeared one month after stopping consumption.", "population_specificity": "44 adults (22 test, 22 control)", "effective_dosage": "10^8 CFU of each strain per lozenge, daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:46.415695+00:00"}
{"study_id": 192646, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus reuteri-containing probiotic lozenges as an adjunct to initial periodontal therapy in patients with chronic periodontitis.", "results_summary": "The test group receiving L. reuteri lozenges showed significant improvements in periodontal parameters (PI, GI, BOP, PD) and attachment gain compared to the control group. Reduced MMP-8 and increased TIMP-1 levels indicated reduced inflammation-associated markers up to day 180.", "population_specificity": "Thirty patients with chronic periodontitis, each having \u22652 teeth per quadrant with probing depths of 5-7 mm and gingival index \u22652.", "effective_dosage": "Not specified", "study_duration": "360 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:47.505483+00:00"}
{"study_id": 192647, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore whether early probiotic supplementation with Lactobacillus Reuteri could prevent functional gastrointestinal disorders (FGIDs) in infants by altering gut microbiota colonization.", "results_summary": "The study suggests that abnormal gut microbiota colonization may contribute to FGIDs like infantile colic, reflux, and constipation, and that Lactobacillus Reuteri supplementation could be a preventive strategy, though specific efficacy results are not detailed in the abstract.", "population_specificity": "Infants in the first months of life.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:52.068390+00:00"}
{"study_id": 192648, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus reuteri on bowel movement frequency and stool consistency in adults with functional constipation.", "results_summary": "L. reuteri significantly increased bowel movement frequency compared to placebo (2.6 vs. 1.0 movements/week, p=0.046), but no significant difference was observed in stool consistency.", "population_specificity": "40 adults (18M/22F, mean age 35\u00b115 years) with functional constipation per Rome III criteria.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:52.073489+00:00"}
{"study_id": 192650, "supplement_id": 1275, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to compare the efficacy of Lactobacillus reuteri versus nystatin in preventing fungal colonization and invasive candidiasis in very low birth weight infants.", "results_summary": "Lactobacillus reuteri was as effective as nystatin in preventing fungal colonization but more effective in reducing proven sepsis and feeding intolerance, with no significant difference in invasive candidiasis rates.", "population_specificity": "Preterm infants with gestational age \u226432 weeks and birth weight \u22641500 g.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:52.979625+00:00"}
{"study_id": 192649, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus reuteri DSM 17938 supplementation on faecal LAB population modulation, GI and cutaneous symptoms, and quality of life in patients with systemic nickel allergy syndrome (SNAS).", "results_summary": "The study found that Lactobacillus reuteri supplementation increased faecal LAB biodiversity and improved GI symptoms, while cutaneous symptoms and abdominal pain decreased in both groups. The probiotic strain showed potential in restoring intestinal homeostasis during a low-Ni diet.", "population_specificity": "Patients suffering from systemic nickel allergy syndrome (SNAS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:53.447099+00:00"}
{"study_id": 192653, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Lactobacillus reuteri supplementation in reducing crying time and successfully treating infantile colic in breastfed infants.", "results_summary": "Lactobacillus reuteri significantly reduced crying times by approximately 56 minutes and increased treatment success in breastfed infants with colic, with effects plateauing at three weeks. The evidence for formula-fed infants remains unresolved.", "population_specificity": "Term, healthy, exclusively breastfed infants with colic.", "effective_dosage": "Not specified", "study_duration": "Three weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:54.483888+00:00"}
{"study_id": 192652, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether prophylactic use of Lactobacillus reuteri DSM 17938 in newborns could reduce the onset of colic, gastroesophageal reflux, and constipation, thereby lowering socioeconomic costs.", "results_summary": "The study found that L. reuteri significantly reduced crying time, regurgitations, and improved bowel movements compared to placebo, while also yielding cost savings for families and communities.", "population_specificity": "Term newborns (<1 week old) in Italy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:54.760536+00:00"}
{"study_id": 192651, "supplement_id": 1275, "safety_score": "100", "efficacy_score": 90, "quality_score": 85, "study_goal": "To evaluate whether daily administration of Lactobacillus reuteri DSM 17938 reduces the frequency and duration of diarrheal episodes and other health outcomes in day school children.", "results_summary": "L. reuteri significantly reduced the frequency and duration of diarrhea and respiratory tract infections, decreased doctor visits, antibiotic use, absenteeism, and parental work absenteeism, with cost savings. No adverse events were reported.", "population_specificity": "Healthy children aged 6-36 months attending day care centers in Mexico.", "effective_dosage": "10^8 colony-forming units daily", "study_duration": "3 months of supplementation, followed by 3 months of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.036684+00:00"}
{"study_id": 192654, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether probiotics, specifically Lactobacillus reuteri, are effective in preventing or managing excessive crying (\"colic\") in infants aged 3 months or younger.", "results_summary": "The study found mixed results, with some trials suggesting Lactobacillus reuteri reduced crying in breastfed infants with colic, while others showed no effect. Meta-analysis of three small trials indicated a significant reduction in crying time for breastfed infants at 21 days, but all trials had potential biases.", "population_specificity": "Infants 3 months or younger, with a focus on breastfed and formula-fed babies with colic.", "effective_dosage": "Not specified", "study_duration": "21 days (for the meta-analysis subset)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:56.170058+00:00"}
{"study_id": 192655, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to replicate previous findings on Lactobacillus reuteri DSMZ17648's ability to reduce H. pylori levels and compare the effects of spray-dried versus freeze-dried cultures.", "results_summary": "The study found a significant reduction in H. pylori levels in the test group but not in the placebo group. Spray-dried L. reuteri was as effective as freeze-dried material, indicating its effect is independent of probiotic activity.", "population_specificity": "22 H. pylori positive, asymptomatic adults", "effective_dosage": "Not specified", "study_duration": "14 days of supplementation, with follow-ups at 6, 12, and 24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:00.201526+00:00"}
{"study_id": 192656, "supplement_id": 1275, "safety_score": "90", "efficacy_score": 30, "quality_score": 85, "study_goal": "To evaluate whether perinatal and infant supplementation with L. reuteri reduced the prevalence of respiratory allergic disease in school age and explore long-term side effects.", "results_summary": "The study found no significant difference in asthma, allergic rhinoconjunctivitis, eczema, or skin prick test reactivity between the probiotic and placebo groups. No severe adverse events were reported, and growth indices and gastrointestinal symptoms were similar in both groups.", "population_specificity": "232 families with allergic disease, of whom 184 completed a 7-year follow-up.", "effective_dosage": "1 \u00d7 10^8 CFU of L. reuteri ATCC 55730.", "study_duration": "Last month of gestation through the first year of life.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:00.257834+00:00"}
{"study_id": 192658, "supplement_id": 1275, "safety_score": "95", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the clinical safety and toxicology of oral ingestion of L. reuteri NCIMB 30242 capsules in human subjects.", "results_summary": "The study found no clinically significant differences in safety parameters between the probiotic and placebo groups, with similar frequency and intensity of adverse events. The results indicate that the tested dosage was safe and well-tolerated over the study period.", "population_specificity": "131 randomized subjects (67 receiving L. reuteri, 64 placebo).", "effective_dosage": "2.9\u00d710\u2079 CFU twice daily.", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:01.525670+00:00"}
{"study_id": 192657, "supplement_id": 1275, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "To evaluate the role of Lactobacillus reuteri supplementation in improving the eradication rate of Helicobacter pylori and reducing antibiotic-associated side-effects during different treatment regimens.", "results_summary": "The sequential treatment regimen with L. reuteri achieved a higher H. pylori eradication rate (88%) compared to the standard 7-day regimen (63%). L. reuteri supplementation reduced the frequency and intensity of antibiotic-associated side-effects, with no significant difference between supplementation during or after antibiotic treatment.", "population_specificity": "90 adult dyspeptic patients (83 completed the study; 30 male, 53 female; mean age 57 \u00b1 13 years) diagnosed with H. pylori infection.", "effective_dosage": "Not specified", "study_duration": "7-day triple therapy or 10-day sequential therapy, with L. reuteri supplementation during or after antibiotic treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:02.665470+00:00"}
{"study_id": 192659, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the colonization and persistence of Lactobacillus reuteri DSM17938 in the gut when administered daily versus on alternate days.", "results_summary": "Both daily and alternate-day dosing led to increased L. reuteri counts during supplementation, with higher initial counts in the alternate-day group. Colonization declined rapidly after dosing stopped, with no significant difference in persistence between the two dosing strategies.", "population_specificity": "Volunteers (n=18)", "effective_dosage": "10^9 CFU per dose, either daily or on alternate days", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:02.733671+00:00"}
{"study_id": 192661, "supplement_id": 1275, "safety_score": "90", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immune-preserving effects of Lactobacillus Reuteri (RC-14) and Lactobacillus rhamnosus (GR-1) supplementation over 25 weeks in HIV patients na\u00efve to anti-retroviral treatment.", "results_summary": "The study found a modest increase in CD4 counts with probiotics compared to placebo, but the differences were not statistically significant. No differences in immune markers, diarrhea incidence, or adverse events were observed between groups.", "population_specificity": "Moderately immune-compromised HIV-positive women na\u00efve to anti-retroviral treatment.", "effective_dosage": "2 x 10^9 CFU/day (twice daily).", "study_duration": "25 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:03.222033+00:00"}
{"study_id": 192662, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the presence of Lactobacillus reuteri in saliva after supplementation and its probiotic effects on plaque index and oral microbiota.", "results_summary": "Supplementation increased L. reuteri in saliva, but it washed out post-intervention. The test group showed no significant plaque index change, unlike the control group, suggesting a potential probiotic effect. No significant impact on supra- or subgingival microbiota was observed.", "population_specificity": "23 healthy individuals", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:03.592870+00:00"}
{"study_id": 192660, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus reuteri supplementation on Th1/Th2 chemokine levels and its association with allergic disease and sensitization in infants.", "results_summary": "Lactobacillus reuteri supplementation was associated with lower Th2-associated chemokines (CCL17, CCL22) and higher Th1-associated chemokine (CXCL11) levels at 6 months. High Th2/Th1 chemokine ratios at birth were linked to allergic disease and sensitization, suggesting L. reuteri may modulate immune balance.", "population_specificity": "Infants from birth to 2 years of age, including those in a double-blind placebo-controlled allergy prevention trial.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Last month of gestation through the first year of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:04.009048+00:00"}
{"study_id": 192663, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential benefits of Lactobacillus reuteri supplementation in managing infantile colic by examining its influence on gut microbiota, motility, and pain perception.", "results_summary": "The study found that Lactobacillus reuteri supplementation may help reduce infantile colic symptoms by modulating gut microbiota and influencing gut motility and pain perception, though the exact mechanisms remain under investigation.", "population_specificity": "Infants within the first 3 months of life suffering from colic.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:07.237476+00:00"}
{"study_id": 192664, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "To determine if long-term oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 supplementation prevents bacterial vaginosis (BV) and enhances the cure rate of metronidazole in women with HIV.", "results_summary": "Probiotics did not enhance BV cure rates when combined with metronidazole but showed potential to prevent BV by improving vaginal flora and pH in women with intermediate vaginal flora.", "population_specificity": "65 HIV-infected women with an aberrant vaginal microbiota (Nugent score 4-10).", "effective_dosage": "Daily probiotics (specific dosage not mentioned).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:08.794409+00:00"}
{"study_id": 192665, "supplement_id": 1275, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to test the efficacy of Lactobacillus reuteri DSM 17 938 in reducing infantile colic symptoms and evaluate its impact on gut microbiota.", "results_summary": "L. reuteri significantly reduced daily crying time compared to placebo, with more responders in the probiotic group. It also increased fecal lactobacilli and reduced E. coli and ammonia levels, with no adverse effects reported.", "population_specificity": "Exclusively breastfed infants diagnosed with colic.", "effective_dosage": "10^8 colony-forming units per day.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:08.977502+00:00"}
{"study_id": 192666, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oral administration of Lactobacillus reuteri ATCC 55730 could modulate cytokine levels (interferon-gamma and interleukin-4) in children with atopic dermatitis.", "results_summary": "The study found that Lactobacillus reuteri supplementation increased interferon-gamma and decreased interleukin-4 levels in exhaled breath condensate of atopic children, suggesting a systemic immunomodulatory effect beyond the intestine. No significant changes were observed in nonallergic subjects or those receiving placebo.", "population_specificity": "Children with atopic and nonallergic dermatitis", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.065495+00:00"}
{"study_id": 192667, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether daily supplementation with Lactobacillus reuteri DSM 17938 could reduce functional abdominal pain (FAP) in children.", "results_summary": "The study found that children supplemented with L. reuteri had significantly lower pain intensity compared to the placebo group, suggesting its potential efficacy in managing FAP.", "population_specificity": "Children aged 6-16 years with functional abdominal pain (FAP) as defined by Rome III criteria.", "effective_dosage": "2\u00d710^8 CFU/day", "study_duration": "4 weeks of supplementation followed by a 4-week follow-up period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.233634+00:00"}
{"study_id": 21337, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of AgNPs-lactoferrin (AgNPs-LTF) complexes in enhancing wound healing in rats.", "results_summary": "The 4 mM AgNPs-LTF gel demonstrated significant wound closure, achieving complete closure by day 10, outperforming both lactoferrin alone and control groups. The AgNPs-LTF complex showed high robustness and effective infection control.", "population_specificity": "Sprague-Dawley rats", "effective_dosage": "1, 2, and 4 mM concentrations of bovine lactoferrin", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.541605+00:00"}
{"study_id": 21336, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore Lactoferrin's neuroprotective mechanisms, particularly its potential to interfere with alpha-synuclein aggregation, iron chelation, and modulation of oxidative stress and neuroinflammation in synucleinopathies like Parkinson's disease.", "results_summary": "The study suggests Lactoferrin may interfere with alpha-synuclein aggregation, modulate oxidative stress and neuroinflammation, and cross the blood-brain barrier, highlighting its potential as a therapeutic agent for neurodegenerative diseases.", "population_specificity": "Neurodegenerative disorders, particularly Parkinson's disease and other synucleinopathies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.740663+00:00"}
{"study_id": 192668, "supplement_id": 1275, "safety_score": "95", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the beneficial effects of Lactobacillus reuteri (DSM 17938) on bowel frequency, stool consistency, and inconsolable crying episodes in infants with functional chronic constipation.", "results_summary": "Infants receiving L. reuteri showed a significantly higher frequency of bowel movements compared to placebo at weeks 2, 4, and 8, but no significant improvements in stool consistency or inconsolable crying episodes were observed. No adverse effects were reported.", "population_specificity": "44 infants (mean age 8.2 months) diagnosed with functional chronic constipation.", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.288545+00:00"}
{"study_id": 21340, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to summarize lactoferrin's molecular mechanisms in anticancer effects, explore its association with cancer progression, and assess its clinical potential as a biomarker and drug delivery carrier.", "results_summary": "Lactoferrin exhibits antibacterial, antiviral, anti-inflammatory, immune-regulatory, and iron metabolism-regulating properties. It inhibits tumor proliferation, invasion, and metastasis through multiple pathways, showing promise for cancer treatment.", "population_specificity": "Not specified (general human body and cancer contexts).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:16.052749+00:00"}
{"study_id": 21338, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether lactoferrin (LF) alleviates non-alcoholic fatty liver disease (NAFLD) in mice by investigating its effects on lipid metabolism, gut microbiota, and the HTR2A-PPAR\u03b1-CPT-1A pathway.", "results_summary": "LF improved lipid metabolism by reducing fatty acid synthesis and increasing lipolysis in the liver, downregulated HTR2A (linked to lipogenesis), and upregulated PPAR\u03b1 and CPT-1A (linked to lipolysis). It also altered gut microbiota composition (increased Adlercreutzia, decreased Clostridia) and raised SCFA levels.", "population_specificity": "Male C57BL/6J mice fed a high-fat, high-cholesterol diet containing cholate (HFCCD).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:16.568337+00:00"}
{"study_id": 21339, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antitumor activity of iron-saturated recombinant human lactoferrin (holo-recHLF) and its complex with oleic acid (OA) compared to apo-recHLF/OA in a murine myeloma model.", "results_summary": "The study found that holo-recHLF/OA complex significantly inhibited tumor growth (93% reduction vs. control), while apo-recHLF/OA showed no inhibition. Holo-recHLF alone had a less pronounced antitumor effect than its complex with OA.", "population_specificity": "Balb/c mice with solid myeloma Sp2/0.", "effective_dosage": "10 mg holo-recHLF with OA (1:8 molar ratio) per animal (0.4 g/kg), daily intraperitoneal injections.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:17.900740+00:00"}
{"study_id": 21342, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether bovine lactoferrin (bLf) enhances antibiotic killing of Staphylococcus aureus (S. aureus) biofilms and its potential therapeutic role in bone infections.", "results_summary": "The study found that bLf significantly enhances the antibiotic cefazolin's (CEF) effectiveness against methicillin-susceptible S. aureus (MSSA) biofilms, eradicating them at 10x minimal inhibitory concentration. Additionally, lactoferrin's bone growth-stimulating properties suggest its potential as a dual-action treatment for bone infections.", "population_specificity": "In vitro-grown biofilms of MSSA (methicillin-susceptible S. aureus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.929405+00:00"}
{"study_id": 21341, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether PXL01, a lactoferrin-derived peptide, improves nerve regeneration in healthy rats and diabetic GK rats following sciatic nerve injury.", "results_summary": "PXL01 increased axonal outgrowth and HSP27 expression in the DRGs of both healthy and diabetic rats but had no impact on macrophage response. Diabetes negatively affected nerve regeneration, but PXL01 showed potential to improve outcomes despite reduced Schwann cell activation.", "population_specificity": "Healthy rats and diabetic Goto-Kakizaki (GK) rats with surgically induced sciatic nerve defects.", "effective_dosage": "Not specified (administered around the autograft immediately after surgery).", "study_duration": "8 days (assessment on day 8 post-intervention).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.991912+00:00"}
{"study_id": 21344, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of bovine lactoferrin (bLF), alone and combined with galacto-oligosaccharides (GOS), on gut microbiota, barrier integrity, and inflammatory response during low-dose iron supplementation in infants.", "results_summary": "The study found that bLF combined with GOS during iron supplementation increased beneficial bacteria (Bifidobacterium and LLP) and SCFA production while inhibiting opportunistic pathogens. It also strengthened the epithelial barrier and reduced inflammation during ETEC infection compared to iron alone.", "population_specificity": "Kenyan weaning infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:20.273011+00:00"}
{"study_id": 21343, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to clarify Lactoferrin's potential and mechanisms in alleviating brain aging, particularly its effects on oxidative stress, neuroinflammation, and the microbiome-gut-brain axis.", "results_summary": "Lactoferrin (500 and 2000 mg/kg) restored body weight, mobility, and spatial memory in aging mice, attenuated neuronal and intestinal barrier damage, increased antioxidant enzymes, reduced inflammatory factors, and restored autophagy via the PI3K/Akt/mTOR pathway. The higher dose (2000 mg/kg) showed the best anti-aging potential.", "population_specificity": "D-galactose-induced brain aging C57BL/6 mice", "effective_dosage": "50, 500, and 2000 mg/kg/day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:20.378540+00:00"}
{"study_id": 21345, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of lactoferrin (LF) as an enhanced agent when combined with marbofloxacin for treating Escherichia coli-induced bovine mastitis.", "results_summary": "The study found that combining lactoferrin with marbofloxacin significantly improved treatment outcomes compared to marbofloxacin alone, with no recurrence of infection. All E. coli isolates were sensitive to marbofloxacin, and LF demonstrated synergistic effects in inhibiting bacterial growth.", "population_specificity": "80 lactating cattle and buffaloes (40 each), aged 4-6 years, suffering from bovine mastitis.", "effective_dosage": "LF (2 mg/ml) combined with marbofloxacin (6 \u03bcg/ml).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:20.741261+00:00"}
{"study_id": 21346, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of lactoferrin as a ligand for targeted drug delivery in breast cancer cells.", "results_summary": "The study highlights lactoferrin's promise as a targeting ligand for drug-loaded nanocarriers, improving delivery accuracy and efficacy in breast cancer cells, potentially enhancing patient outcomes.", "population_specificity": "Breast cancer cells (in vitro or preclinical context, not specified in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:23.361358+00:00"}
{"study_id": 21347, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the current knowledge on Lactoferrin's role in cancer, including its potential synergistic effects with conventional drugs and its molecular mechanisms of antitumor activity.", "results_summary": "The study found that Lactoferrin exhibits a broad spectrum of biological activities, including anticancer effects, and may enhance the efficacy of conventional drugs while reducing their side effects. However, the precise molecular mechanisms of its antitumor activity require further investigation.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effects with conventional drugs mentioned, but no specific interactions detailed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:24.353837+00:00"}
{"study_id": 21348, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether SP-LF hybrid hydrolysates exhibit synergistic antioxidant and anti-fatigue effects in murine models.", "results_summary": "The study found that SP-LF hybrid hydrolysates demonstrated superior antioxidant activity (DPPH, ABTS scavenging, iron reduction) and anti-fatigue effects (prolonged swimming time, improved glycogen levels, reduced fatigue markers) compared to single hydrolysates, likely mediated by the Keap1/Nrf2/HO-1 pathway and PGC-1\u03b1 upregulation.", "population_specificity": "Murine models (mice)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:25.890019+00:00"}
{"study_id": 21349, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess changes in lactoferrin levels during different phases of schizophrenia and explore its relationship with cognitive symptoms and performance.", "results_summary": "Serum lactoferrin levels significantly decreased from the acute phase to post-treatment, with no correlation to symptom severity but an inverse correlation with executive function improvements. Cognitive functions (verbal memory, working memory, executive function) improved significantly post-treatment.", "population_specificity": "30 patients diagnosed with schizophrenia.", "effective_dosage": "Not specified", "study_duration": "From hospital admission to resolution of acute symptoms (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:27.295791+00:00"}
{"study_id": 21350, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether lactoferrin-modified liposomes (Lf-Dios-Lcl) could enhance diosmetin's brain-targeting properties and anti-neuroinflammatory effects in an intracerebral hemorrhage (ICH) model.", "results_summary": "Lf-Dios-Lcl effectively reduced neuroinflammation by decreasing proinflammatory cytokines (IL-1\u03b2, TNF-\u03b1), increasing anti-inflammatory IL-10, and promoting microglial polarization toward the M2 phenotype via p38 pathway inhibition in ICH model rats.", "population_specificity": "Rats with induced intracerebral hemorrhage (ICH).", "effective_dosage": "1 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:27.950594+00:00"}
{"study_id": 21352, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate Lactoferrin's role in apoptosis regulation and its potential as an anticancer agent through molecular docking analysis.", "results_summary": "The study found that Lactoferrin disrupts XIAP's inhibition of Caspase-3 and Caspase-9, potentially restoring apoptotic signaling, and stabilizes Caspase-3, enhancing its activation. Weaker interactions were observed with Fas, Bcl-2, and Akt, suggesting modulation of key apoptotic regulators.", "population_specificity": "Not specified (in silico/molecular docking study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:28.364470+00:00"}
{"study_id": 21353, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Chitosan/Alginate microparticles could enhance Lactoferrin's stability, bioavailability, and antibacterial efficacy in simulated gastrointestinal conditions.", "results_summary": "The study found that Chitosan/Alginate microparticles effectively protected Lactoferrin from degradation in gastric conditions, ensured controlled release in intestinal conditions, and maintained its antibacterial activity against Escherichia coli. FT-IR and zeta-potential analyses revealed Lactoferrin's interaction with bacterial LPS, destabilizing bacterial membranes.", "population_specificity": "Not specified (in vitro study using simulated gastrointestinal conditions and Escherichia coli).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:28.606070+00:00"}
{"study_id": 21351, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects and mechanisms of lactoferrin and HIF-1\u03b1 on dry eye syndrome (DED) in mice.", "results_summary": "Lactoferrin treatment significantly improved tear secretion, goblet cell count, and protein expression levels (Bcl-2, STAT3) while reducing corneal damage and apoptosis markers (Bax, TUNEL positivity) in DED model mice. The effects were comparable to DMOG, a known HIF-1\u03b1 stabilizer.", "population_specificity": "DED model mice and human DED patients (for tear analysis).", "effective_dosage": "50 mg/kg dissolved in 2 mL PBS, administered orally daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:28.834591+00:00"}
{"study_id": 21354, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "To develop a lactoferrin-modified nanoparticle system for co-delivering levodopa and curcumin to enhance neuroprotective efficacy and achieve brain-targeted delivery in Parkinson's disease.", "results_summary": "The lactoferrin-modified nanoparticle system (Lf-lip@LC-MSNs) significantly improved brain-targeted delivery, reduced oxidative stress and \u03b1-synuclein accumulation, and enhanced neuronal survival and motor function recovery in PD models.", "population_specificity": "MPTP-induced Parkinson's disease mouse models and rotenone-damaged neuronal models.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:31.633391+00:00"}
{"study_id": 21355, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential of a lactoferrin-derived chimera for treating multiple myeloma by assessing its effects on cancer cell growth and apoptosis mechanisms.", "results_summary": "The lactoferrin-derived chimera effectively inhibited multiple myeloma cell growth, induced apoptosis, and triggered oxidative stress leading to mitochondrial dysfunction, without affecting normal cells. It initiated caspase-independent apoptosis via nuclear translocation of apoptosis-inducing factor and endonuclease G.", "population_specificity": "Multiple myeloma cell lines (MM1S, MM1R, RPMI8226) and normal peripheral blood mononuclear cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:32.080042+00:00"}
{"study_id": 21357, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of oral lactoferrin versus IV iron dextran in managing anemia caused by chronic kidney disease (CKD) in pediatric patients.", "results_summary": "Oral lactoferrin demonstrated superior efficacy in improving Hb, RBCs, MCH, iron, RDW-SD, MCHC, IL-6, and GDF-15 levels compared to IV iron dextran, though no significant differences were observed between the two groups after 3 months of treatment.", "population_specificity": "60 pediatric patients diagnosed with CKD-related anemia.", "effective_dosage": "100 mg of oral lactoferrin daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.531977+00:00"}
{"study_id": 21356, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of combining photobiomodulation therapy, active oxygen, and lactoferrin (Blue\u00aeM) in managing medication-related osteonecrosis of the jaw (MRONJ).", "results_summary": "The combination treatment led to complete pain relief (from 3/10 to 0/10), soft tissue healing, and improved bone density on CT scans, suggesting efficacy in MRONJ management.", "population_specificity": "A 62-year-old female with hypertension, rheumatoid arthritis, osteoporosis, and MRONJ following bisphosphonate use.", "effective_dosage": "Blue\u00aeM teeth&bone once daily for 30 days, Blue\u00aeM gel applied topically every morning for 15 days, and Blue\u00aeM mouthwashes nightly for 30 days.", "study_duration": "30 days for primary treatment, with follow-up at 60 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.678733+00:00"}
{"study_id": 21358, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether steroid hormone receptors (estrogen and glucocorticoid) play roles in Lactoferrin (LF) synthesis and secretion in bovine mammary epithelial cells (BMECs).", "results_summary": "Estrogen (E2) and hydrocortisone significantly promoted BMEC proliferation, increased ER and GR expression, and stimulated LF synthesis and secretion. Inhibitors (fulvestrant, mifepristone, pimozide) reduced LF gene transcript and protein levels, confirming ER and GR involvement in LF regulation.", "population_specificity": "Bovine mammary epithelial cells (BMECs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.798198+00:00"}
{"study_id": 21360, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-inflammatory effects of lactoferrin + disodium guanosine monophosphate therapy in CKD patients by analyzing its impact on inflammatory markers.", "results_summary": "The study found a significant decrease in inflammatory markers (TNF-\u03b1, IL-6, IL-10) in the group receiving the study drug, suggesting its potential as an anti-inflammatory intervention for CKD. Secondary endpoints like hemoglobin and eGFR showed nonsignificant improvements.", "population_specificity": "40 patients with chronic kidney disease (CKD), randomized into two groups of 20 each.", "effective_dosage": "Not specified", "study_duration": "29 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:36.158417+00:00"}
{"study_id": 21361, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of lactoferrin-conjugated nanoparticles (LF-NP) for targeted delivery of radicicol to prostate cancer cells to enhance efficacy and reduce off-target effects.", "results_summary": "Lactoferrin nanoparticles encapsulated with radicicol (Ra-LF-NP) showed higher inhibitory potential, reducing spheroid area by 80% and invasiveness compared to radicicol alone, suggesting improved targeted delivery and efficacy in prostate cancer cells.", "population_specificity": "Androgen-sensitive LNCaP and androgen-negative PC-3 prostate cancer cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:36.457836+00:00"}
{"study_id": 21362, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether calcium phosphate nanoparticles with immobilized lactoferrin and heparin could serve as effective intraoral disinfectants for preventing and treating dental infections.", "results_summary": "The study found that lactoferrin-immobilized CaP nanoparticles exhibited high immobilization efficiency (over 90%) and antibacterial activity against Actinomyces naeslundii, a bacterium involved in dental plaque formation. The nanoparticles were well-dispersed in water and showed potential as intraoral disinfectants.", "population_specificity": "Not specified (in vitro study targeting dental pathogens).", "effective_dosage": "Not specified (concentrations of lactoferrin and heparin varied for optimization).", "study_duration": "Not specified (likely short-term in vitro testing).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:37.507371+00:00"}
{"study_id": 21363, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the molecular mechanisms of lactoferrin's effects on cancer and non-cancer cells under hypoxic conditions, particularly its role in altering sensitivity to radiation therapy.", "results_summary": "Lactoferrin showed cytotoxic activity in both cancer and non-cancer cells, with hypoxic conditions increasing sensitivity in some cancer cells but decreasing it in non-cancer cells. It altered radiation sensitivity by regulating apoptosis and NRF2 signaling in a cell type-specific manner.", "population_specificity": "Cancer (HSC2) and non-cancer (KD) cell lines under hypoxic conditions.", "effective_dosage": "High-dose (specific amount not mentioned).", "study_duration": "Treatment within 3 hours of irradiation (duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:40.342370+00:00"}
{"study_id": 21364, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of lactoferrin-functionalized liposomes (NCA-Lips-Lf) for targeted therapy of hepatocellular carcinoma (HCC) compared to sodium demethylcantharidate (Na2DCA).", "results_summary": "The study found that NCA-Lips-Lf significantly improved antitumor activity, with an 85.29% tumor inhibition rate compared to 59.13% for Na2DCA, while reducing adverse effects like vascular irritation, cardiotoxicity, and nephrotoxicity. The formulation also enhanced tumor-targeting accumulation and prolonged circulation time.", "population_specificity": "Sprague-Dawley (SD) rats and H22 tumor-bearing BALB/c mice.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:41.773095+00:00"}
{"study_id": 21368, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the effects and mechanisms of Lactoferrin (LF) in preventing organ fibrosis and evaluate its potential as a treatment for fibrotic diseases.", "results_summary": "The review highlights LF's multifunctional benefits, including antioxidant, anti-inflammatory, and antimicrobial effects, and its protective role against fibrosis in various disease models. It suggests LF could be a promising natural substance for preventing and alleviating fibrotic diseases.", "population_specificity": "Not specified (general focus on organ fibrosis in chronic diseases)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:43.840568+00:00"}
{"study_id": 21369, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a stable nanoemulsion of lactoferrin (LTF) and eicosapentaenoic acid (EPA) and investigate its macro- and molecular properties.", "results_summary": "The study found that 1.0% LTF formed the most stable complex with EPA, enhancing emulsion stability against storage and freezing/thawing. Molecular simulations revealed the binding mechanism and dynamic reaction process of the LTF-EPA complex.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "1.0% LTF concentration", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:44.219017+00:00"}
{"study_id": 21365, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of oral Lactoferrin supplementation in reducing infection-related outcomes (late-onset sepsis, diarrhea, and upper respiratory infections) in children under 18 years old.", "results_summary": "Lactoferrin supplementation was associated with significantly fewer cases of late-onset sepsis and diarrhea but showed no significant reduction in upper respiratory infections. Mortality among late-onset sepsis studies was also analyzed, though specific results were not detailed in the abstract.", "population_specificity": "Children under 18 years old, including neonates.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:44.641974+00:00"}
{"study_id": 21370, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate lactoferrin's anti-inflammatory effects on astrocytes and its potential to induce astrocyte reprogramming into neurons under sustained inflammation.", "results_summary": "Lactoferrin reduced astrocyte reactivity by lowering TLR4, GFAP, and IL-6 expression while increasing IL-10 and NRF2. It also promoted astrocyte reprogramming into neuroblasts via SOX2 overexpression.", "population_specificity": "DI-TNC1 astrocyte cell line", "effective_dosage": "4 \u03bcg/mL for 24 hours", "study_duration": "Observations at 2, 9, and 16 days post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:45.150153+00:00"}
{"study_id": 21367, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review lactoferrin's antiparasitic and immunomodulatory properties, focusing on its mechanisms of action and potential as a natural treatment against human parasites.", "results_summary": "Lactoferrin demonstrated antiparasitic effects by chelating iron, limiting parasite survival and pathogenicity. The review highlighted its efficacy against various intracellular and extracellular parasites, supported by in vitro and in vivo studies over 40 years.", "population_specificity": "Human parasites (intracellular and extracellular, intestinal or blood-borne)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:45.486269+00:00"}
{"study_id": 21371, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Lactoferrin's anti-liver cancer effects on hepatocellular carcinoma (HCC) cells and assess its preventive efficacy in a murine model.", "results_summary": "Lactoferrin showed anti-proliferative effects on HCC cells (HepG2, Hep3B, SK-Hep1) without harming healthy liver cells (FL83B), induced mitochondrial-mediated apoptosis and cell cycle arrest, and prevented HCC development in mice. INTL1 was identified as the receptor facilitating LF endocytosis in HepG2 cells.", "population_specificity": "HCC cells (HepG2, Hep3B, SK-Hep1) and healthy liver cells (FL83B) in vitro; nude mice with orthotopic HepG2 cell injection in vivo.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:49.566845+00:00"}
{"study_id": 21372, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop an oral astaxanthin delivery formulation using lactoferrin-responsive flocculation to improve targeted delivery and therapeutic efficacy for inflammatory bowel disease (IBD).", "results_summary": "The lactoferrin-responsive formulation significantly improved colon length and achieved a 100% survival rate in IBD therapy, primarily through enhanced immunoregulation, epithelial repair, and gut microbiota remodeling.", "population_specificity": "In vivo model (specific species not mentioned in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:50.374839+00:00"}
{"study_id": 21373, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of lactoferrin-modified nanoparticles for enhancing brain-targeted delivery of Bromocriptine Mesylate in Parkinson's disease treatment.", "results_summary": "The lactoferrin-modified nanoparticles improved cellular transport, brain targeting efficiency, behavioral regulation, antioxidant effects, and neuroprotection in Parkinson's mouse models.", "population_specificity": "Haloperidol-induced Parkinson's disease mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:50.968347+00:00"}
{"study_id": 21375, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore Lactoferrin's role in cancer, comparing the mechanisms of human and bovine Lf isoforms in tumorigenesis and cancer progression.", "results_summary": "Both human and bovine Lactoferrin showed substantial anticancer activity, influencing processes like cell growth, apoptosis, and angiogenesis, though human Lf may have context-dependent risks like increased carcinogenesis at high levels.", "population_specificity": "Not specified (general cancer-related mechanisms).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:52.179147+00:00"}
{"study_id": 21377, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the safety and efficacy of melatonin-coated lactoferrin-chitosan nanoparticles for targeted colorectal cancer therapy.", "results_summary": "The nanoparticles demonstrated significant cytotoxicity in HCT116 cells, enhanced cellular uptake, tumor reduction in vivo, and improved pharmacokinetics with sustained drug release and biocompatibility. They also showed antimicrobial effects and positive impacts on the gut microbiome.", "population_specificity": "DMH-induced colorectal cancer rat model and HCT116 human colorectal cancer cells.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:53.689108+00:00"}
{"study_id": 21376, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of Lactoferrin-conjugated extracellular nanovesicles (LF-EVs) as a targeted drug delivery system for melanoma treatment.", "results_summary": "LF-EVs demonstrated enhanced specificity for melanoma cells, minimized off-target effects, and promoted efficient intracellular drug release. They also showed potential to inhibit melanoma progression and metastasis while supporting antitumor immune responses.", "population_specificity": "Melanoma cells (in vitro or preclinical models, not specified for human trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:53.936441+00:00"}
{"study_id": 21374, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a recombinant Lactococcus lactis strain expressing lactoferrin peptides (LL-EFLmC) could inhibit avian pathogenic E. coli (APEC-O78) infection, improve immune response, and restore gut microbiota in chickens.", "results_summary": "LL-EFLmC showed inhibitory effects against APEC-O78 and Staphylococcus aureus in vitro, improved chicken growth metrics (daily intake and feed efficiency), enhanced immune markers (serum IgG and intestinal SIgA), reduced pro-inflammatory cytokines, and restored disrupted gut microbiota.", "population_specificity": "Chickens (avian pathogenic E. coli O78-challenged)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:54.461563+00:00"}
{"study_id": 21379, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dietary supplementation with lactoferrin could protect thyroid tissue in Experimental Autoimmune Thyroiditis (EAT) rats by reducing oxidative stress, endoplasmic reticulum stress, and inflammation.", "results_summary": "Lactoferrin significantly reduced oxidative stress and inflammatory cell infiltration in thyroid tissue, inhibited endoplasmic reticulum stress, and alleviated cellular apoptosis in EAT rats. Its protective effects were primarily mediated through the inhibition of the mTOR signaling pathway.", "population_specificity": "Experimental Autoimmune Thyroiditis (EAT) rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:57.506929+00:00"}
{"study_id": 21378, "supplement_id": 1276, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the anticancer potential of camel milk-derived lactoferrin peptides, particularly PEP66, against breast cancer cells using in silico and in vitro methods.", "results_summary": "PEP66 exhibited strong anticancer activity against MCF-7 breast cancer cells with a low IC50 value (52.82 \u03bcg/mL) and high selectivity index (3.19), indicating lower toxicity to normal cells. Molecular docking and dynamics simulations revealed stable interactions with HER2 catalytic site residues, suggesting its potential as an effective anticancer agent.", "population_specificity": "MCF-7 breast cancer cells and HDFa normal cells (in vitro).", "effective_dosage": "52.82 \u03bcg/mL (IC50 value for PEP66).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:58.126365+00:00"}
{"study_id": 21380, "supplement_id": 1276, "safety_score": "95", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the oral toxicity, toxicokinetic properties, and immunotoxicity of human lactoferrin (effera\u2122) produced in Komagataella phaffii in rats.", "results_summary": "No toxicologically significant changes were observed in clinical, hematological, biochemical, or histopathological assessments. Effera\u2122 was well tolerated at doses up to 2000 mg/kg/day, approximately 400 times the proposed human intake.", "population_specificity": "Adult Sprague-Dawley rats", "effective_dosage": "200, 600, and 2000 mg/kg body weight per day", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:58.768249+00:00"}
{"study_id": 21381, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the immunomodulatory effects of bovine Lactoferrin (bLf) during SARS-CoV-2 infection, focusing on its impact on immune response pathways and cytokine production.", "results_summary": "The study found that bLf binds strongly to TLR4/NF-\u03baB, modulates immune gene expression, reduces NK cell populations, and alters cytokine levels (e.g., decreased IL-6, increased CCL5). In infected mice, bLf increased pro-inflammatory markers and restored FTH1 levels in brain tissue.", "population_specificity": "Peripheral blood mononuclear cells (PBMCs) from healthy and COVID-19 participants, and K18-hACE2 mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:00.909413+00:00"}
{"study_id": 21382, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 92, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effectiveness of lactoferrin (Lf) as a docking protein for IR-1048 to enhance NIR-II optical characteristics and assess its potential for multimodal imaging-guided phototherapy in tumor treatment.", "results_summary": "Lf@IR-1048 demonstrated superior NIR-II optical properties, high photothermal conversion efficiency (41.9%), and strong tumor-targeting capabilities, achieving a 94.8% tumor inhibition rate. It also enhanced dendritic cell maturation and cytotoxic T lymphocyte infiltration, showing significant antitumor activity in photo-immunotherapy.", "population_specificity": "Bilateral CT26 tumor-bearing mice (in vivo) and tumor cells (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:02.158918+00:00"}
{"study_id": 21383, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the immunogenicity and alloimmunization potential of recombinant human lactoferrin (rhLF) compared to bovine lactoferrin (bLF) in healthy adults.", "results_summary": "The study found no significant increase in anti-hLF antibodies or adverse events following rhLF ingestion, with safety outcomes similar across groups and within normal ranges. Anti-bLF antibody levels increased in the bLF group but not in the rhLF groups, indicating no alloimmunization risk for rhLF.", "population_specificity": "Healthy adults", "effective_dosage": "High-dose rhLF (3.4 g/d), low-dose rhLF (0.34 g/d), or bLF (3.4 g/d)", "study_duration": "28-day supplementation period with follow-up visits on Days 56 and 84", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:02.967177+00:00"}
{"study_id": 21384, "supplement_id": 1276, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to characterize the molecular mechanisms of bovine lactoferrin (bLF) on nerve extension in PC12 cells and compare its effects to nerve growth factor (NGF).", "results_summary": "bLF significantly enhanced neurite outgrowth in PC12 cells, similar to NGF, likely mediated via the TrkA receptor and phosphorylated ERK signaling pathway. Higher doses (600-1000 \u00b5g/mL) reduced cell viability, while 250 \u00b5g/mL promoted neurite growth.", "population_specificity": "PC12 cells (a rat adrenal pheochromocytoma cell line)", "effective_dosage": "0.01-1000 \u00b5g/mL (effective dose: 250 \u00b5g/mL)", "study_duration": "24-72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:03.559969+00:00"}
{"study_id": 21385, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review lactoferrin's biological functions and protective effects against COVID-19, with a focus on pregnant women and infants.", "results_summary": "The study found conflicting results on lactoferrin's efficacy as an adjuvant in COVID-19 therapy, likely due to varying study designs. It suggests lactoferrin could be beneficial, especially for infants and pregnant women, but existing clinical trials have poorly evaluated these subpopulations.", "population_specificity": "Pregnant women and their infants.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:04.916925+00:00"}
{"study_id": 21386, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of astrocytic lactoferrin in the pathological process of Parkinson's disease (PD) and its influence on dopaminergic neuron survival.", "results_summary": "The study found that astrocytic lactoferrin deficiency exacerbated PD-like manifestations, including dopaminergic neuron loss, mitochondrial dysfunction, and motor deficits, particularly after MPTP treatment. It also identified disruptions in glutamate/calcium homeostasis, mitochondrial dynamics, and ER-mitochondria signaling as key mechanisms.", "population_specificity": "Mice with astrocyte-specific lactoferrin knockout (Lf-cKO) and MPTP-treated mice as a PD model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:06.576399+00:00"}
{"study_id": 21366, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate changes in tear lactoferrin levels and cytokine profiles in postmenopausal women with PANDO complicated by OMGD to explore potential pathological mechanisms.", "results_summary": "The study found that lactoferrin levels were lower in the PANDO with OMGD group compared to the Non-PANDO with OMGD group, while pro-inflammatory cytokine levels were significantly elevated.", "population_specificity": "Postmenopausal women with and without primary acquired nasolacrimal duct obstruction (PANDO), subdivided by the presence or absence of obstructed meibomian gland dysfunction (OMGD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:06.984576+00:00"}
{"study_id": 21387, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of bovine lactoferrin (bLf) as an adjuvant combined with AMP (N6) in treating E. coli-induced bacterial enteritis.", "results_summary": "The combination of bLf and N6 significantly reduced inflammatory markers (TNF-\u03b1, IL-6), increased anti-inflammatory IL-10, improved intestinal barrier function, and enhanced intestinal morphology in ETEC-infected mice.", "population_specificity": "Female ICR mice with ETEC K88-induced bacterial enteritis.", "effective_dosage": "100 mg/kg bLf alone or combined with 10 mg/kg or 20 mg/kg N6.", "study_duration": "Three consecutive days of ETEC infection followed by treatment (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:07.061959+00:00"}
{"study_id": 21389, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to analyze the effects of native and iron-saturated bovine lactoferrin in reversing dysbiosis and oxidative stress induced by clindamycin in a murine model.", "results_summary": "Lactoferrin reversed clindamycin-induced protein carbonyl increases and reduced inflammatory cytokine expression (IL-6 and TNF-\u03b1) to basal levels, demonstrating protective effects against dysbiosis and oxidative stress.", "population_specificity": "Male C57BL/6 mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:08.098634+00:00"}
{"study_id": 21391, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a supplement containing nucleotides and lactoferrin in maintaining or improving the clinical and laboratory outcomes of canine leishmaniosis in seropositive dogs.", "results_summary": "The supplement maintained stable clinical scores, improved antibody titres, and reduced progression to active leishmaniosis in treated dogs compared to placebo, with no reported side effects.", "population_specificity": "Leishmania infantum-seropositive dogs not requiring leishmanicidal/leishmaniostatic treatment.", "effective_dosage": "1 tablet per 10 kg of weight once every 24 hours.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:10.818509+00:00"}
{"study_id": 21390, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of a product containing lactoferrin and biomimetic hydroxyapatite in reducing dentin hypersensitivity symptoms and counteracting inflammation in supporting tissues.", "results_summary": "The study found a progressive decrease in dentin hypersensitivity symptoms over time, with significant improvements observed at four and eight weeks of follow-up, indicating the product's effectiveness.", "population_specificity": "105 patients aged 28-65 with at least two hypersensitive teeth due to erosions, abrasions, gingival recessions, and/or periodontal diseases.", "effective_dosage": "Applied three times daily with a soft-bristled toothbrush or topically as a gel on affected teeth.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:11.902117+00:00"}
{"study_id": 21392, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to develop and evaluate a bifunctional injectable hydrogel (Lf/NZ2114/LMSH) for its antimicrobial and pro-healing effects in treating Staphylococcus aureus-induced wound infections.", "results_summary": "The hydrogel demonstrated strong antimicrobial activity (bactericidal rate >99.92%) and nearly 100% wound healing rate in a mouse model, along with anti-inflammatory effects, tissue restoration, and angiogenesis. The healed wounds showed improved tissue structure with more hair follicles and glands.", "population_specificity": "Mouse wound infection model (S. aureus-induced).", "effective_dosage": "Not specified.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:12.251748+00:00"}
{"study_id": 21393, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the antidepressant-like effects of lactoferrin and its mechanism of action through gut flora metabolism in a rat model of depression.", "results_summary": "Lactoferrin intervention improved depression-like behaviors in rats, increased intestinal tight junction protein expression, reduced inflammatory markers, and regulated gut flora metabolism, suggesting a potential role in alleviating depression via the microbiota-gut-brain axis.", "population_specificity": "7-week-old male Sprague-Dawley rats subjected to chronic unpredictable mild stress.", "effective_dosage": "2% lactoferrin in water (2 g/100 ml).", "study_duration": "44 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:13.011002+00:00"}
{"study_id": 21394, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether astrocytic lactoferrin overexpression could inhibit neuronal ferroptosis and improve cognitive function in Alzheimer's disease models.", "results_summary": "Astrocytic lactoferrin overexpression reduced iron accumulation, increased GPX4 expression, and inhibited neuronal ferroptosis in APP/PS1 mice. Human lactoferrin treatment also prevented iron-induced ferroptosis by enhancing LRP1 internalization and stabilizing GPX4.", "population_specificity": "APP/PS1 mice (Alzheimer's disease model) and in vitro human cell studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:14.612144+00:00"}
{"study_id": 21396, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the hepatic and immune-modulating effects of bovine lactoferrin (LF), selenium nanoparticles (SeNPs), or their combination (LF/SeNPs) against bleomycin-induced liver injury in rats.", "results_summary": "The study found that LF, SeNPs, and their combination significantly improved bleomycin-induced hepatic damage by modulating oxidative stress, inflammatory markers, and liver function parameters, with the LF/SeNPs combination showing the greatest efficacy.", "population_specificity": "Adult male rats (160-200 g)", "effective_dosage": "LF (200 mg/kg/day), SeNPs (0.0486 mg/kg/day), or LF/SeNPs combination (200.0486 mg/kg/day)", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:15.619340+00:00"}
{"study_id": 21397, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether lactoferrin nanoparticles could effectively deliver rifampicin to target and eliminate intracellular bacteria in infected macrophages.", "results_summary": "The study found that Rif@Lf NPs specifically targeted infected macrophages, increased rifampicin accumulation, adhered to bacteria within macrophages, and released rifampicin in a redox-responsive manner, demonstrating broad-spectrum antibiotic activity against intracellular bacteria and biofilms with high safety and therapeutic efficacy in multiple infection models.", "population_specificity": "Disease models of subcutaneous infection, sepsis, and bacterial keratitis (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:15.927144+00:00"}
{"study_id": 21395, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lactoferrin exhibits neuroprotective effects in a rotenone-induced cellular model of Parkinson's disease (PD).", "results_summary": "Lactoferrin pre-treatment (1-10 \u00b5g/ml) reduced cell viability loss, mitochondrial membrane potential impairment, reactive oxygen species generation, and pro-apoptotic activities in rotenone-exposed cells. It also modulated key apoptotic and signaling proteins (Bax:Bcl2 ratio, p42/44 MAPK, and pAkt).", "population_specificity": "Differentiated SH-SY5Y neuroblastoma cells (dopaminergic neuron model).", "effective_dosage": "1-10 \u00b5g/ml (pre-treatment for 48 hours).", "study_duration": "48 hours (pre-treatment) followed by 24 hours of rotenone exposure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:16.047158+00:00"}
{"study_id": 21398, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of a dietary intervention on lactoferrin concentrations in human milk and assess daily, circadian, and between-breast variations.", "results_summary": "The dietary intervention significantly reduced lactoferrin concentrations in human milk, though the effect size was small. Lactoferrin levels varied significantly within and across days but not between breasts.", "population_specificity": "Lactating mothers", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:18.860971+00:00"}
{"study_id": 21399, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects and mechanisms of free curcumin and curcumin embedded in nano-micelles (M(Cur)) on oxidative stress-induced injury in brain vascular endothelial cells (bEnd.3 cells).", "results_summary": "Micellar curcumin at 10 \u03bcg mL-1 improved cell morphology, increased viability, restored mitochondrial membrane potential, and reduced reactive oxygen species generation in bEnd.3 cells under oxidative stress, indicating enhanced protection compared to free curcumin.", "population_specificity": "bEnd.3 brain vascular endothelial cells (in vitro study)", "effective_dosage": "10 \u03bcg mL-1", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:20.158708+00:00"}
{"study_id": 21400, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the enhanced bioactivity of Valpalf\u00ae, a new lactoferrin formulation, compared to native bovine lactoferrin (bLf) in terms of iron-binding capacity, resistance to digestion, nuclear accumulation, and anti-inflammatory/antioxidant effects.", "results_summary": "Valpalf\u00ae demonstrated superior iron-binding capacity, resistance to tryptic digestion, and greater nuclear accumulation compared to native bLf. It effectively reduced IL-6 levels in stimulated macrophages, modulated antioxidant enzyme expression, and improved hematological parameters in a retrospective study on anemia of inflammation in thrombophilic women.", "population_specificity": "Hereditary thrombophilic pregnant and non-pregnant women with anemia of inflammation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:20.922547+00:00"}
{"study_id": 21401, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antifungal activity of human lactoferrin-based peptide hLF(1-11) against Malassezia furfur strains and its potential synergistic effects with conventional antifungal drugs.", "results_summary": "hLF(1-11) inhibited the growth of all tested M. furfur strains with MIC values ranging from 12.5 to 100 \u03bcg/mL. Combining hLF(1-11) with fluconazole or amphotericin showed synergistic or additive effects, enhancing the efficacy of these antifungal drugs.", "population_specificity": "30 strains of M. furfur covering known IGS1 genotypic variation.", "effective_dosage": "12.5 to 100 \u03bcg/mL (concentration, not dosage frequency specified).", "study_duration": "Not specified.", "interactions": "Synergistic or additive effects with fluconazole and amphotericin.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:21.431402+00:00"}
{"study_id": 21405, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether lactoferrin supplementation reduces diarrhoea incidence and improves nutritional recovery in Kenyan children with comorbid diarrhoea and wasting.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or not yet concluded.", "population_specificity": "Kenyan children aged 6-24 months with mid-upper arm circumference <12.5 cm recovering from diarrhoea and wasting.", "effective_dosage": "Not specified", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:22.959825+00:00"}
{"study_id": 21402, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactoferrin (LF) acts through the LF receptor (LfR) in the brain and how dietary LF supplementation affects LfR expression and cognitive function in piglets.", "results_summary": "LF supplementation increased LfR protein expression in specific brain regions (occipital lobe, subventricular zone) and improved working memory in piglets, with a positive correlation between LfR protein levels and cognitive performance. The effects varied by brain region and dosage, with no clear dose-response relationship.", "population_specificity": "Piglets (postnatal days 3 to 38).", "effective_dosage": "Low (155 mg/kg/day) and high (285 mg/kg/day) LF supplementation.", "study_duration": "35 days (from postnatal day 3 to 38).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:23.484106+00:00"}
{"study_id": 21404, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of a combination supplement (PIRV-F20\u00ae) containing lactoferrin and other components on exercise capacity in post-COVID-19 patients.", "results_summary": "Patients taking PIRV-F20\u00ae showed a significant improvement in 6-minute walking distance compared to controls, but no differences were observed in muscular strength, echocardiographic parameters, or symptom perception.", "population_specificity": "Post-COVID-19 patients (\u226518 years) with persistent symptoms and exercise impairment, excluding severe comorbidities or pregnancy/breastfeeding.", "effective_dosage": "Not specified", "study_duration": "At least 6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:24.222544+00:00"}
{"study_id": 21403, "supplement_id": 1276, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop lactoferrin (Lf)/CD133 antibody conjugated nanostructured lipid carriers (Lf/CD133-NLCS) to simultaneously target the blood-brain barrier (BBB) and glioma stem cells (GSCs) for improved glioblastoma multiforme (GBM) therapy.", "results_summary": "Lf/CD133-NLCS-TMZ showed high-efficiency anti-tumor effects against U87-MG cells and GSCs, with no significant toxicity to normal cells at concentrations below 200 \u03bcg ml-1. It also demonstrated increased BBB permeability and higher cellular uptake compared to unconjugated counterparts.", "population_specificity": "Malignant glioma cells (U87-MG) and glioma stem cells (GSCs).", "effective_dosage": "Concentrations lower than 200 \u03bcg ml-1.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:24.795650+00:00"}
{"study_id": 21406, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of lactoferrin, with or without iron supplementation, on improving hemoglobin levels and inflammatory markers in anemic patients with advanced chronic kidney disease (CKD).", "results_summary": "Oral lactoferrin significantly improved hemoglobin levels in CKD patients after four weeks, with greater improvement observed in women and those receiving iron supplementation. Effects on inflammatory markers were non-significant.", "population_specificity": "Adult patients (>18 years) with stage 5 CKD (eGFR <15 ml/min/1.73 m\u00b2) and anemia (Hb <10 g/dl, Tsat >20%).", "effective_dosage": "100 mg twice daily", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:27.201848+00:00"}
{"study_id": 21407, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how covalent bonding between lactoferrin and EGCG affects the interfacial properties of protein particles and the stability of high internal phase Pickering emulsions (HIPPEs).", "results_summary": "The study found that the LF-EGCG covalent complex improved interfacial properties (e.g., increased molecular flexibility, viscoelasticity) and enhanced HIPPE stability, droplet size, \u03b6-potential, and 3D printing performance. It also increased free fatty acid release compared to the control.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:28.045424+00:00"}
{"study_id": 21409, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether lactoferrin could improve fatigue, anxiety, depression, cognitive failure, and muscle strength in long COVID patients.", "results_summary": "Lactoferrin showed no significant benefit over placebo in reducing fatigue or other symptoms at 6 or 12 weeks, despite both groups showing some improvement at 6 weeks.", "population_specificity": "Long COVID patients aged 18-70 years within 12 months of proven SARS-CoV-2 infection.", "effective_dosage": "1200 mg daily", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:28.924281+00:00"}
{"study_id": 21408, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of bovine lactoferrin (bLf) in treating symptoms of interstitial cystitis/painful bladder syndrome (IC/PBS) in women.", "results_summary": "The study found that bLf treatment significantly reduced IC/PBS episodes, improved bladder appearance, and decreased serum IL-6 and D-dimers in hereditary thrombophilia patients, with no reported side effects.", "population_specificity": "Women with IC/PBS, including those with hereditary thrombophilia.", "effective_dosage": "Valpalf\u00ae capsules (containing bLf plus sodium bicarbonate and citrate), exact dosage not specified.", "study_duration": "17 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:30.107230+00:00"}
{"study_id": 21410, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess the efficacy of combining tibolone with a Lactobacilli mixture and bovine lactoferrin for treating vestibulodynia related to atrophy in postmenopausal women.", "results_summary": "The combination therapy significantly reduced vulvar burning/pain and improved pain evaluation scores after 90 days of treatment. The study concluded that the treatment was effective in alleviating vestibular pain and hypersensitivity.", "population_specificity": "Postmenopausal women with at least 1 year of amenorrhea, experiencing vulvar burning/pain and introital dyspareunia.", "effective_dosage": "Bovine lactoferrin (as part of Respecta\u00ae) taken once daily (specific dosage not detailed).", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:31.398726+00:00"}
{"study_id": 21411, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential anticoccidial effects of lactoferrin (LF) alone and in combination with diclazuril in broiler chickens experimentally infected with Eimeria tenella.", "results_summary": "Treatment with LF and/or diclazuril demonstrated potent antioxidant and anticoccidial effects, reducing oocyst shedding, lesion scores, and lymphocytic infiltrates while improving antioxidant and immune systems in chickens. LF restored histopathological changes and biochemical alterations caused by E. tenella infection.", "population_specificity": "One-day-old broiler chickens experimentally infected with Eimeria tenella.", "effective_dosage": "250 mg/kg of diet (LF), administered daily.", "study_duration": "From one day of age until the end of the study (duration not explicitly stated in the abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:32.702743+00:00"}
{"study_id": 21412, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the organ-level effects and gene expression changes of bovine Lactoferrin (bLf) in the cutaneous repair process, particularly its role in regulating iron homeostasis and preventing ferroptotic damage.", "results_summary": "bLf controlled the expression of PHGPx, SLC7A11, and SLC40A1 genes, reduced iron deposition in liver, kidney, and intestinal tissues, and suppressed iron-driven ferroptosis and inflammation-induced anemia. The effects were statistically significant in kidney and liver tissues but not in intestinal tissue.", "population_specificity": "Male Sprague Dawley rats (180-250 g) fed a high-fat diet.", "effective_dosage": "200 mg/kg/day, oral", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:32.784190+00:00"}
{"study_id": 21413, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of bovine lactoferrin (bLf) on serum ferritin levels and related markers in patients with hyperferritinemia unrelated to hereditary hemochromatosis.", "results_summary": "Treatment with bLf significantly reduced serum ferritin, CRP, and D-dimers while increasing red blood cells, hemoglobin, and hematocrit. Effects were consistent across most patients, though one on a higher dosage showed particularly strong reductions in inflammatory markers.", "population_specificity": "17 patients with hyperferritinemia unrelated to hereditary hemochromatosis.", "effective_dosage": "200 mg/day (n=14) or 400 mg/day (n=3), administered once or twice daily before meals.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:34.029652+00:00"}
{"study_id": 21414, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review advancements in nanotechnology-based delivery methods for Lactoferrin to improve its therapeutic potential in treating ocular diseases.", "results_summary": "The study highlights Lactoferrin's multifunctional benefits for ocular health, including antimicrobial, immunoregulatory, anti-inflammatory, and antioxidant activities, and discusses innovations like Lf-loaded contact lenses and nanocapsules to enhance drug stability and bioavailability.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:34.139780+00:00"}
{"study_id": 21416, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the capacity of a new photo-detection device to measure tear lactoferrin levels as a tool for differentiating between Sj\u00f6gren's syndrome dry eye disease and non-Sj\u00f6gren's dry eye disease.", "results_summary": "The study found significantly lower lactoferrin concentrations in patients with both non-Sj\u00f6gren's and Sj\u00f6gren's syndrome dry eye disease compared to controls, with Sj\u00f6gren's patients showing the lowest levels. The newly developed photo-detection device effectively differentiated between these conditions.", "population_specificity": "Patients with non-Sj\u00f6gren's dry eye disease (n=54), Sj\u00f6gren's syndrome dry eye disease (n=52), and healthy controls (n=11).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:36.773310+00:00"}
{"study_id": 21418, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-Mucorale action of native lactoferrin (LF) and its functional fragments, as well as their synergistic effects with antifungal agents.", "results_summary": "The study found that all three Mucor species were inhibited by LF fragments, and native LF showed the best synergistic action against Mucorales when combined with Amphotericin B.", "population_specificity": "Three common Mucorale species (specific species not named in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic action noted with Amphotericin B, isavuconazole, and posaconazole.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:37.643274+00:00"}
{"study_id": 21417, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a thermally stable co-delivery system for lactoferrin (LF) and iron(II) to address iron deficiency anemia by improving LF thermal stability and iron(II) solubility.", "results_summary": "The study found that LF-S.NaCas-Fe complexes achieved high loading capacities for both LF and iron(II), significantly improved LF thermal stability, and retained 68%-90% of LF after thermal treatment with minimal iron(II) release. The secondary structure of LF was well preserved during thermal treatment.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Iron(II) loading capacities ranged from 2.5 to 12 mg g\u207b\u00b9; LF loading capacities ranged from 250 to 690 mg g\u207b\u00b9.", "study_duration": "Thermal treatment was applied for 5 minutes at 95\u00b0C.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:38.316099+00:00"}
{"study_id": 21419, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lactoferrin (LF) could mitigate pancreatic tissue damage caused by prolonged hydroxychloroquine (HCQ) administration in rats.", "results_summary": "LF coadministration with HCQ ameliorated pancreatic tissue damage, reducing disruptions in acinar architecture, congested islets of Langerhans, and elevated plasma insulin, amylase, and lipase levels.", "population_specificity": "Adult male Wister albino rats", "effective_dosage": "2 g/kg (LF)", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:38.912304+00:00"}
{"study_id": 21421, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lactoferrin could mitigate arsenic-induced nephrotoxicity by reducing inflammation, apoptosis, redox imbalance, and fibrosis in renal tissue.", "results_summary": "The study found that lactoferrin, particularly at 200 mg/kg, effectively counteracted arsenic-induced nephrotoxicity by preserving renal tissue architecture and reducing oxidative stress, inflammation, apoptosis, and fibrosis.", "population_specificity": "Male C57BL/6 mice (6 weeks old)", "effective_dosage": "100, 200, and 400 mg/kg body weight (daily)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:41.932720+00:00"}
{"study_id": 21420, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the bone-homing and active-targeting potential of lactoferrin (Lf) in a dual-decorated nanostructured lipid carrier (Aln/Lf/IVM-NLC) for targeted leukemia therapy.", "results_summary": "The study found that Aln/Lf/IVM-NLC demonstrated significant antileukemic cytotoxicity, higher cellular uptake, and nuclear fragmentation in K562 cells, along with upregulation of caspase-3 and BAX. It also showed enhanced bone homing and lower off-target distribution compared to untargeted NLC.", "population_specificity": "In vitro (K562 leukemia cells) and in vivo (bone localization studies) models.", "effective_dosage": "1 mg/mL (Aln/Lf/IVM-NLC).", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:41.994499+00:00"}
{"study_id": 21422, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the physicochemical and functional properties of lactoferrin-hyaluronic acid (LF-HA) complexes prepared by ultrasonic and thermal treatment methods.", "results_summary": "The LF-HA complexes showed improved heat stability, foaming stability, emulsifying activity, and antioxidant capacity, but reduced foaming ability. Iron binding ability improved only with thermal treatment, and in vitro digestibility decreased compared to lactoferrin alone.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:42.869170+00:00"}
{"study_id": 21423, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether lactoferrin-coated lipid nanocapsules (LF-APO-LNC) could improve brain targetability and prolong residence time of apocynin (APO) and lavender oil (LAV) to counteract seizures.", "results_summary": "LF-APO-LAV/LNC showed increased brain accumulation (Log BB value of 0.2 \u00b1 0.14), reduced seizure severity (Modified Racine score of 0.67 \u00b1 0.47), and improved oxidant/antioxidant capacity and inflammatory markers in brain tissue.", "population_specificity": "PTZ-induced seizures rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:44.003884+00:00"}
{"study_id": 21426, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate lactoferrin's potential as a therapeutic option for Candida-associated denture stomatitis (CADS), either alone or in combination with existing treatments.", "results_summary": "The study highlights lactoferrin's broad-spectrum anti-fungal effects against Candida species, suggesting its potential as a monotherapy or adjunct treatment for oral stomatitis. Current research supports its role in reducing microbial invasion and managing CADS.", "population_specificity": "Individuals with Candida-associated denture stomatitis (CADS) or oral candidiasis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:45.343600+00:00"}
{"study_id": 21425, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of lactoferrin on the expression levels of ATG101, mTOR, and AMPK genes in the MCF7 breast cancer cell line and explore its potential role in inducing autophagy through protein interactions.", "results_summary": "Lactoferrin reduced the expression levels of ATG101, mTOR, and AMPK genes in MCF7 cells at various concentrations. In silico analysis showed lactoferrin interacts with key domains of these proteins, suggesting it may induce autophagy through protein interactions rather than gene expression.", "population_specificity": "MCF7 breast cancer cell line", "effective_dosage": "100, 400, 600, and 800 \u03bcg/ml", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:45.709041+00:00"}
{"study_id": 21427, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-allergic effects of lactoferrin in combination with polymethoxyflavonoids and the mechanism of inhibition in degranulation.", "results_summary": "Lactoferrin showed strong degranulation inhibition when used alone and exhibited synergistic effects when combined with nobiletin, significantly downregulating phospholipase C\u03b31 phosphorylation and suppressing degranulation via Ca2+-dependent and independent pathways.", "population_specificity": "Rat basophilic leukemia cell line RBL-2H3.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic interaction with nobiletin noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:46.454627+00:00"}
{"study_id": 21429, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if lactoferrin (LFcinB11) could effectively inhibit NCAM polysialylation and the release of neutrophil extracellular traps (NETs) compared to other compounds.", "results_summary": "The study found that LFcinB11 was a better candidate for inhibiting NCAM polysialylation than CMP and low-molecular-weight heparin (LMWH) and also effectively inhibited the release of NETs, suggesting its potential as a bifunctional inhibitor.", "population_specificity": "Not specified (in vitro or animal model implied by NMR studies and molecular mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:47.034317+00:00"}
{"study_id": 21430, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to study the non-covalent and covalent binding of chlorogenic acid (CA) and bovine lactoferrin (BLF) to improve functional activity and create milk-based delivery systems.", "results_summary": "The study found that CA-BLF complexes showed structural changes, providing more active sites and better functional activity compared to control BLF. These couplings could be used to encapsulate bioactive compounds in milk-based delivery systems.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Different concentrations under neutral conditions (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:49.558726+00:00"}
{"study_id": 21431, "supplement_id": 1276, "safety_score": "85", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the oral toxicity of recombinant human lactoferrin (rhLF) in rats to determine its safety profile and appropriate dosage for future toxicology studies.", "results_summary": "The study found that Helaina rhLF was well tolerated in rats at doses up to 2000 mg/kg/day, with no significant adverse effects reported. The results suggest that this high dose is suitable for further toxicology studies.", "population_specificity": "Adult Sprague Dawley rats (3-6 rats/sex/dose).", "effective_dosage": "200, 1000, and 2000 mg/kg body weight per day.", "study_duration": "14 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:50.372693+00:00"}
{"study_id": 21432, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the quality, conformational stability, glycosylation heterogeneity, and antimicrobial activity of Lactoferrin (LTF) from different sources and after heat treatment.", "results_summary": "The study found that native mass spectrometry (nMS) and glycoproteomics effectively characterized LTF's purity, glycosylation, and thermal stability. Heat treatment significantly reduced nMS peak intensity and antimicrobial activity, which were positively correlated.", "population_specificity": "Not specified (in vitro study on LTF samples).", "effective_dosage": "Not specified.", "study_duration": "Not specified (focused on production and storage processes).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:51.127956+00:00"}
{"study_id": 21433, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether recombinant lactoferrin (LF) expressed in inactivated probiotics could improve metabolic-related disorders, particularly glucose tolerance and insulin sensitivity, in obese mice.", "results_summary": "The study found that recombinant LF (in SK-HM1/LF) improved glucose tolerance more than other probiotic formulations, though it did not enhance insulin sensitivity. LF-expressing probiotics also showed potential benefits in reducing inflammation and improving lipid profiles (triglycerides and cholesterol).", "population_specificity": "Obese mice induced by a 13-week high-fat diet.", "effective_dosage": "Not specified (daily oral administration via gavage).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:52.215797+00:00"}
{"study_id": 21434, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lactoferrin could alleviate acute alcohol-induced liver injury (AALI) by mitigating ferroptosis and iron overload.", "results_summary": "Lactoferrin significantly reduced alcohol-induced liver injury in vitro and in vivo by inhibiting ferroptosis markers (ACSL4, GPX4), reducing oxidative stress (MDA, GSH), and alleviating iron overload (TFR, DMT1, FPN, FTH).", "population_specificity": "AML12 cells (in vitro) and unspecified animal models (in vivo).", "effective_dosage": "In vitro: 10, 20, 40 \u03bcg/mL; in vivo: 100 and 200 mg/kg BW.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:53.782680+00:00"}
{"study_id": 192755, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of oral bovine lactoferrin supplementation on feeding intolerance and intestinal permeability in preterm infants.", "results_summary": "The study found that preterm infants receiving bovine lactoferrin achieved full enteral feeding faster (9 vs. 15 days) and had significantly lower serum zonulin concentrations (3.38 vs. 5.49 ng/ml), indicating improved feeding tolerance and reduced intestinal permeability.", "population_specificity": "Preterm infants (26-34 weeks gestational age) with feeding intolerance.", "effective_dosage": "100 mg/day bovine lactoferrin.", "study_duration": "4 weeks or until discharge.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:55.067501+00:00"}
{"study_id": 21435, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the chemopreventive effects of holo-bLf in different hepatocellular carcinoma (HCC) models, including its potential to prevent HCC or enhance existing treatments.", "results_summary": "A single dose of holo-bLf prevented early carcinogenic events in an HCC model, reduced preneoplastic lesions, and decreased tumor burden in xenotransplanted mice. Combined with sorafenib, holo-bLf synergistically reduced HepG2 viability by arresting cells in the G0/G1 phase.", "population_specificity": "Diethylnitrosamine-induced HCC in vivo model and HepG2 xenotransplanted mice.", "effective_dosage": "200 mg kg-1 (single dose for prevention; frequency for treatment not specified).", "study_duration": "Not specified for treatment; single dose for prevention.", "interactions": "Synergistic effect with sorafenib noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:55.846821+00:00"}
{"study_id": 192759, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of lactoferrin in reducing dysgeusia in chemotherapy patients.", "results_summary": "The study found that lactoferrin at 250 mg thrice daily significantly mitigated dysgeusia in chemotherapy patients (p < 0.001). The results were statistically significant, though sample sizes were smaller compared to other treatments like zinc.", "population_specificity": "Chemotherapy patients experiencing dysgeusia.", "effective_dosage": "250 mg thrice daily.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:56.395001+00:00"}
{"study_id": 192760, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of a mind-body-medicine stress management and lifestyle modification program on Crohn's disease patients, including monitoring fecal lactoferrin as a secondary inflammatory biomarker.", "results_summary": "The study found improvements in fecal lactoferrin levels after 9 months in the intervention group, suggesting reduced inflammation, though it was a secondary outcome and not the primary focus.", "population_specificity": "Patients (18-75 years) with mild to moderate Crohn's disease and stable medication.", "effective_dosage": "Not specified", "study_duration": "9 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:58.233975+00:00"}
{"study_id": 192763, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the efficacy of lactoferrin in reducing sepsis and mortality in term neonates after gastrointestinal surgery and its impact on enteral feeding, gut microflora, and hospital stay.", "results_summary": "The study found no published randomized controlled trials assessing lactoferrin's efficacy for postoperative management in term neonates after gastrointestinal surgery, highlighting a gap in evidence.", "population_specificity": "Term neonates (born at 37 or more weeks of gestation) who underwent gastrointestinal surgery within 28 days of birth.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:59.296353+00:00"}
{"study_id": 192762, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the antimicrobial activities of bovine lactoferrin (BLF) and lactoferricin (LFcin), as well as their effects on probiotic growth and molecular pathway modulation.", "results_summary": "BLF and LFcin exhibit broad antimicrobial activity but show limited effects on most probiotic strains. BLF and its hydrolysate can promote the growth of specific probiotics, depending on culture conditions, dosage, and strain. BLF supplementation modulates key molecular pathways or genes.", "population_specificity": "Not specified (general mammalian context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:59.358336+00:00"}
{"study_id": 192765, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specifically address the study's goal regarding Lactoferrin.", "results_summary": "The abstract mentions Lactoferrin only in the context of stool studies for diarrhea in COVID-19 patients, without detailing its effects.", "population_specificity": "COVID-19 patients with gastrointestinal symptoms, particularly diarrhea.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:01.146971+00:00"}
{"study_id": 192764, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the clinical efficacy and safety of bovine lactoferrin in improving outcomes for hospitalized patients with moderate-to-severe COVID-19.", "results_summary": "The study found no significant differences in primary outcomes (death/ICU admission or discharge/NEWS2 \u2264 2) between lactoferrin and placebo groups. Lactoferrin demonstrated excellent safety and tolerability but did not show clinical benefit for COVID-19 patients.", "population_specificity": "Hospitalized adult patients with moderate-to-severe COVID-19.", "effective_dosage": "800 mg per day, oral administration.", "study_duration": "14 days from enrollment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:01.839130+00:00"}
{"study_id": 192767, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether bovine lactoferrin (bLF) could prevent SARS-CoV-2 infection in healthcare personnel.", "results_summary": "The study found no significant difference in SARS-CoV-2 infection rates between the bLF and placebo groups, nor any effect on time to symptomatic infection or secondary outcomes.", "population_specificity": "Healthcare personnel in two tertiary hospitals in Lima, Peru.", "effective_dosage": "600 mg daily", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:03.067978+00:00"}
{"study_id": 192754, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if HBV infection alters breast milk composition, specifically lactoferrin levels, and whether newborns of HBV-positive mothers require additional lactoferrin supplementation.", "results_summary": "The study found that HBV infection decreased lactoferrin concentrations in breast milk (average 537.68 pg/mL), suggesting that additional lactoferrin supplementation may be necessary for newborns of HBV-positive mothers.", "population_specificity": "Pregnant women with HBV infection and their newborns, compared to a healthy control group.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:03.595904+00:00"}
{"study_id": 192766, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of donor milk processing techniques, including pasteurization, on the digestion and absorption of lactoferrin and other milk components in preterm infants.", "results_summary": "Heating during pasteurization increased proteolysis of lactoferrin and caseins but did not affect protein hydrolysis in vitro; the abundance and diversity of released peptides remain unclear. Fat homogenization improved fat digestion, while high-pressure processing showed minimal impact compared to Holder pasteurization.", "population_specificity": "Preterm infants receiving donor human milk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:05.028115+00:00"}
{"study_id": 192768, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "To determine the impact of supplemental bovine lactoferrin on the gut microbiome and metabolome of preterm infants.", "results_summary": "The study found minimal impacts of lactoferrin on gut microbiome diversity and composition, with hospital site and postnatal age explaining more variation. No significant differences in microbiome Shannon diversity were observed between lactoferrin and placebo groups.", "population_specificity": "Preterm infants born <32 weeks' gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:06.402527+00:00"}
{"study_id": 192769, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of human milk (containing lactoferrin) and formula milk on infant gut microbiome and health.", "results_summary": "The study highlights that lactoferrin, as a bioactive component in human milk, contributes to immunological development and promotes a healthy gut microbiome in infants. Formula milk supplemented with prebiotics or probiotics attempts to mimic these effects but results in differing gut microbiomes compared to breastfed infants.", "population_specificity": "Infants (specifically comparing breastfed and formula-fed infants)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:07.006344+00:00"}
{"study_id": 192770, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of a food supplement containing lactoferrin, combined with a topical cream, in treating adult female acne.", "results_summary": "The combination treatment (C + O) showed significantly greater reduction in inflammatory lesions and acne severity scores compared to the topical treatment alone, with a 73% reduction in inflammatory lesions and a 55% improvement in AFAST score at Week 12. Both treatments were well tolerated with no adverse events reported.", "population_specificity": "Adult women aged 25\u201340 with adult female acne (AFA).", "effective_dosage": "Not specified (combined with prebiotics, zinc, and niacinamide in a food supplement).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:07.554949+00:00"}
{"study_id": 192772, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether lactoferrin supplementation could prevent preterm birth in women at high risk.", "results_summary": "Lactoferrin supplementation was associated with a lower risk of preterm birth before 37 weeks (OR=0.43) and higher gestational age at delivery (MD=0.46 weeks). However, its role in preventing preterm birth via inflammatory modulation remains unclear.", "population_specificity": "Pregnant women at high risk for preterm birth.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:08.768546+00:00"}
{"study_id": 192771, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine the evidence for the effect of Lactoferrin supplementation on inflammation, immune function, and respiratory tract infections in humans.", "results_summary": "Lactoferrin supplementation reduced systemic inflammation in adults (notably IL-6) and improved immune function in some studies. It also reduced respiratory tract infection incidence in infants and children but not in adults.", "population_specificity": "Human subjects of all ages (20 studies in adults, 5 in children).", "effective_dosage": "200 mg Lf/day for inflammation; 35-833 mg Lf/day in formulas for RTIs.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:10.187630+00:00"}
{"study_id": 192773, "supplement_id": 1276, "safety_score": "80", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of prophylactic enteral bovine lactoferrin in preventing severe neonatal diseases (e.g., LOS, NEC) in premature infants.", "results_summary": "Lactoferrin did not reduce the incidence of LOS, NEC, or overall mortality but significantly accelerated the achievement of full enteral feeds and reduced hospital stay duration in the smallest infants.", "population_specificity": "Premature infants with gestational age \u226432 weeks, birth weight \u22641,500 g, and age \u226472 hours.", "effective_dosage": "100 mg/day", "study_duration": "Until postmenstrual age of 36 weeks or discharge (at least 4 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:11.381337+00:00"}
{"study_id": 192774, "supplement_id": 1276, "safety_score": "80", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to identify the effects of orally administered lactoferrin in preventing and managing viral infections across different virus families.", "results_summary": "The study found heterogeneous results with no clear conclusion on lactoferrin's antiviral effects, though some weak positive outcomes were noted in symptom severity, duration, and viral load reduction. Most trials had high risk of bias, and findings varied widely across viral families.", "population_specificity": "People of any age with confirmed viral infections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:11.397425+00:00"}
{"study_id": 192775, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential role of lactoferrin as an immunomodulatory and antimicrobial supplement for preventing and treating COVID-19.", "results_summary": "The study suggests lactoferrin has potential utility in COVID-19 due to its immunomodulatory and antimicrobial properties, though clinical data specific to COVID-19 is limited.", "population_specificity": "Not specified (general discussion, no specific population studied).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:12.540821+00:00"}
{"study_id": 192776, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of Lactoferrin, Metformin, and TUDCA on high glucose-induced cellular stress in INS1 \u03b2-cells and MSCs.", "results_summary": "Lactoferrin, along with Metformin and TUDCA, effectively mitigated high glucose-induced cellular stress, restored proliferation and migration in MSCs, and normalized glucose-stimulated insulin secretion in INS1 \u03b2-cells. The effects were observed at the gene and protein expression levels.", "population_specificity": "INS1 \u03b2-cells and mesenchymal stem cells (MSCs) in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:14.943481+00:00"}
{"study_id": 192778, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review Lactoferrin's potential as an antiviral and immune regulator for COVID-19 prevention and adjunct treatment.", "results_summary": "The study highlights Lactoferrin's in vitro antiviral efficacy against SARS-CoV-2 and its immunomodulatory effects, suggesting potential benefits for COVID-19, but clinical validation is pending.", "population_specificity": "Not specified (general potential application for COVID-19).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:15.809161+00:00"}
{"study_id": 192779, "supplement_id": 1276, "safety_score": "100", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the clinical benefits and safety of enteral lactoferrin supplementation in preterm neonates based on evidence from randomized controlled trials.", "results_summary": "Lactoferrin supplementation showed clinical benefits in reducing late-onset sepsis, late-onset fungal sepsis, hospital length of stay, and urinary tract infections, with no reported adverse effects. However, it did not significantly decrease necrotizing enterocolitis, mortality, or neurodevelopmental impairment.", "population_specificity": "Preterm neonates", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:16.080713+00:00"}
{"study_id": 192777, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the preventative effects of bovine lactoferrin (bLF) on late-onset sepsis (LOS) in infants with a birth weight <1500 g and its relation to human milk intake.", "results_summary": "The study evaluated bLF's effectiveness in preventing culture-proven or probable LOS in very low birth weight infants, combining data from two randomized controlled trials with similar designs and dosages.", "population_specificity": "Infants with a birth weight <1500 g.", "effective_dosage": "200 mg\u00b7(kg body mass)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:16.326116+00:00"}
{"study_id": 192780, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the effects of lactoferrin supplementation, in combination with other nutrients, on gut microbiota development and markers of gut barrier maturation in healthy term infants.", "results_summary": "Infants fed formula containing BMOS (which included lactoferrin) showed lower calprotectin levels and microbiota profiles closer to breastfed infants, suggesting improved gut maturation. No significant differences were observed for neopterin.", "population_specificity": "Healthy term infants in their early life.", "effective_dosage": "Not specified", "study_duration": "First four weeks of life", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:18.157971+00:00"}
{"study_id": 192782, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess whether bovine lactoferrin (bLf) supplementation disrupts intestinal microbiota development in preterm infants receiving prophylactic probiotics.", "results_summary": "The study found that bLf supplementation had minimal impact on microbiota composition or function, with no significant differences in taxa relative abundance or functional gene content between groups. Infants receiving bLf showed higher species richness, but the overall effect on microbiota development was negligible.", "population_specificity": "Preterm infants less than 31 weeks gestational age.", "effective_dosage": "100 mg bLf daily, mixed with feeds (human milk or formula).", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:19.409978+00:00"}
{"study_id": 192781, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplementing the enteral diet of very low-birthweight infants with lactoferrin reduces all-cause mortality or major morbidity.", "results_summary": "Lactoferrin supplementation did not significantly improve death or major morbidity but might reduce late-onset sepsis, as indicated by a meta-analysis of over 5000 infants. Three serious adverse reactions occurred, but none were definitively attributed to lactoferrin.", "population_specificity": "Very low-birthweight or preterm infants (weighing less than 1500 g and aged less than 8 days).", "effective_dosage": "200 mg/kg once daily.", "study_duration": "Until 34 weeks' post-menstrual age (or for 2 weeks, if longer), or until discharge from the study hospital if earlier.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:20.209428+00:00"}
{"study_id": 192783, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of undenatured whey protein isolate (WPI) with standardized lactoferrin content on oxidative stress and inflammation in individuals with type 2 diabetes mellitus.", "results_summary": "The WPI group showed significant reductions in markers of oxidative stress and inflammation, improved lipid profile, and reduced fasting plasma glucose compared to placebo. No changes were observed in body weight, BMI, or other metabolic markers in either group.", "population_specificity": "120 white patients with type 2 diabetes and glycated hemoglobin \u22656.5%.", "effective_dosage": "Not specified (only lactoferrin content \u22650.7% in WPI).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:21.559515+00:00"}
{"study_id": 192784, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether bovine lactoferrin supplementation could prevent late-onset sepsis (LOS) and neurodevelopmental delay in low birth weight neonates.", "results_summary": "Bovine lactoferrin did not significantly reduce the incidence of LOS or sepsis-associated death compared to placebo, though there was a non-significant trend favoring lactoferrin. Neurodevelopment and growth outcomes at 24 months were similar between groups, but bronchiolitis rates were significantly lower in the lactoferrin group.", "population_specificity": "Neonates with birth weights of 500-2000 g in Lima, Peru.", "effective_dosage": "200 mg/kg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:23.174737+00:00"}
{"study_id": 192785, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to systematically review and meta-analyze the role of lactoferrin supplementation in preventing late-onset sepsis (LOS) in preterm infants.", "results_summary": "Lactoferrin supplementation, with or without probiotics, reduced the incidence of all LOS (RR: 0.56; 95% CI: 0.36-0.86). The evidence was of low to moderate quality, suggesting a beneficial effect, but further research is needed to confirm these findings.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:24.033058+00:00"}
{"study_id": 192786, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether bovine lactoferrin (BLF) supplementation reduces late-onset sepsis (LOS) in preterm infants, particularly comparing its effectiveness in those fed mother's own milk (MM) versus formula/donor milk (no-MM).", "results_summary": "BLF supplementation significantly reduced LOS incidence in preterm infants, with a relative risk reduction of 0.66 (95% CI: 0.18-0.64) in MM-fed infants. The study suggests BLF may be more effective in infants not exclusively fed MM, warranting further investigation.", "population_specificity": "Preterm neonates", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:24.846114+00:00"}
{"study_id": 192787, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether supplementation with lactoferrin is effective in preventing necrotising enterocolitis (NEC) or infection in very preterm infants.", "results_summary": "The study found that supplementation with lactoferrin, among other immunonutrients, was not effective in preventing NEC or infection in very preterm infants based on randomized controlled trials.", "population_specificity": "Very preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:25.144861+00:00"}
{"study_id": 192789, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether bovine lactoferrin (bLF), combined with GOS and vitamin D, could restore TLR responsiveness in pDCs and mDCs and reduce inflammatory markers in elderly women.", "results_summary": "The study found that the nutritional intervention (bLF, GOS, and vitamin D) improved TLR-mediated responses in dendritic cells and reduced inflammatory markers in serum, suggesting potential benefits for immune function in aging.", "population_specificity": "Elderly women", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:27.243614+00:00"}
{"study_id": 192790, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether adding bovine lactoferrin (bLF) to feeds in very-low birthweight (VLBW) infants improves survival free from major morbidities and other clinical outcomes.", "results_summary": "The study is designed to evaluate the impact of bLF on survival free from brain injury, sepsis, NEC, and retinopathy, as well as secondary outcomes like time to full enteral feeds and hospital stay, but results are not yet available (pre-results).", "population_specificity": "Very-low birthweight (VLBW) infants (<1500 g) in Australia and New Zealand.", "effective_dosage": "Up to 250 mg/kg/day bLF added to breast milk or formula.", "study_duration": "Until 34 completed weeks corrected gestation or for 2 weeks (whichever is longer), or until discharge if earlier.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:29.619225+00:00"}
{"study_id": 192791, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine the effects of vitamin D\u2083 supplementation on salivary immune functions and symptoms of upper respiratory tract infection (URTI) in vitamin D-insufficient taekwondo athletes.", "results_summary": "The abstract does not provide results related to Lactoferrin.", "population_specificity": "25 male taekwondo athletes, aged 19\u207b22 years, with vitamin D insufficiency.", "effective_dosage": "5000 IU/day of vitamin D\u2083.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:30.158610+00:00"}
{"study_id": 192793, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize lactoferrin's role in protecting newborns from infection and supporting immune system maturation, as well as review clinical trials on its use for preventing sepsis and necrotizing enterocolitis.", "results_summary": "Lactoferrin exhibits antimicrobial and immunomodulatory functions, playing a critical role in neonatal infection protection and immune system development. Clinical trials suggest potential benefits in preventing sepsis and necrotizing enterocolitis, warranting further study.", "population_specificity": "Newborn infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:32.011431+00:00"}
{"study_id": 192792, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility of lactoferrin supplementation as a treatment for taste and smell abnormalities (TSA) in chemotherapy patients and investigate related mechanisms through salivary proteome analysis.", "results_summary": "Lactoferrin supplementation significantly reduced salivary Fe concentration, increased immune protein expression, and decreased TSA scores in chemotherapy patients, while also improving oral immunity.", "population_specificity": "19 cancer patients with TSA post-chemotherapy and 12 healthy subjects.", "effective_dosage": "3 tablets per day (250 mg per tablet).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:32.024287+00:00"}
{"study_id": 192795, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine if prophylactic enteral bovine lactoferrin supplementation reduces late-onset invasive infection and other complications in very preterm infants.", "results_summary": "The study is ongoing, so no results are reported yet; it will assess infection incidence, mortality, and other outcomes, with potential follow-up on neurodevelopmental impacts at 5 years.", "population_specificity": "Very preterm infants (born at < 32 weeks' gestation) in UK neonatal care centres.", "effective_dosage": "150 mg/kg/day", "study_duration": "From shortly after birth until 34 weeks' post-menstrual age", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:33.151755+00:00"}
{"study_id": 192794, "supplement_id": 1276, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether lactoferrin supplementation could prevent late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) in preterm infants while assessing its safety.", "results_summary": "Lactoferrin significantly reduced the incidence of LOS, NEC, hospital-acquired infections, and infection-related mortality, while also shortening the time to full enteral feeding. No adverse effects were reported.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:33.383608+00:00"}
{"study_id": 192796, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether bovine lactoferrin (BLF) supplementation could counteract the increased risk of late-onset sepsis (LOS) in preterm infants exposed to inhibitors of gastric acidity.", "results_summary": "The study found that BLF supplementation reduced the additional risk of LOS associated with inhibitors of gastric acidity exposure, lowering the risk increase from 7.7% per day in untreated infants to 1.2% per day in treated infants. BLF was particularly effective against Gram-negative and fungal pathogens.", "population_specificity": "Very low birth weight (VLBW) preterm infants in the neonatal intensive care unit.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Inhibitors of gastric acidity (H2 blockers or proton pump inhibitors).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:36.194244+00:00"}
{"study_id": 192797, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine if daily supplementation with lactoferrin and lysozyme could reduce environmental enteric dysfunction (EED) and stunting in rural Malawian children aged 12-23 months.", "results_summary": "The abstract does not provide results, as it describes a planned study rather than reporting outcomes.", "population_specificity": "Rural Malawian children aged 12-23 months at high risk for EED and stunting.", "effective_dosage": "Not specified in the abstract.", "study_duration": "16 weeks (primary outcomes measured at 8 and 16 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:37.567267+00:00"}
{"study_id": 192798, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether probiotics, including Lactoferrin, had any significant effects on immune responses in sedentary young males following resistance exercise.", "results_summary": "The study found no significant differences in salivary Lactoferrin levels between groups or between pre- and post-test measurements, indicating no detectable effect of probiotics or circuit training on Lactoferrin responses.", "population_specificity": "Forty-one healthy sedentary young males.", "effective_dosage": "Not specified for Lactoferrin (probiotics were administered twice daily).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:39.229683+00:00"}
{"study_id": 192803, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers examined whether vitamin D3 supplementation affects salivary lactoferrin secretion rates in athletes during winter training.", "results_summary": "The study did not report significant changes in lactoferrin secretion rates in either the vitamin D3 or placebo groups.", "population_specificity": "39 healthy male athletes", "effective_dosage": "5000 IU/day of vitamin D3", "study_duration": "14 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:40.051521+00:00"}
{"study_id": 192801, "supplement_id": 1276, "safety_score": "90", "efficacy_score": 30, "quality_score": 75, "study_goal": "To determine the tolerability of bovine lactoferrin (bLF) in very preterm infants and assess whether the intervention could be adequately masked.", "results_summary": "The study found no effect of bLF on feeding tolerance, mortality, late-onset sepsis, or other complications of prematurity. Parents in both groups equally believed their infants received bLF, indicating successful masking.", "population_specificity": "Very preterm infants under 31 weeks gestation.", "effective_dosage": "100 mg per day.", "study_duration": "Intervention began before 48 hours of age; duration to achieve full feeds (140 ml/kg per day) was measured.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:40.253606+00:00"}
{"study_id": 192800, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and tolerability of short-term supplementation with bovine whey-derived lactoferrin and immunoglobulins in free-living adults.", "results_summary": "Supplementation was well tolerated with no significant adverse effects, and routine clinical measures remained largely unchanged. Body composition and metabolic indices showed minor fluctuations but no significant differences between groups.", "population_specificity": "Free-living adults (n=20 per group).", "effective_dosage": "200 mg lactoferrin, 200 mg or 800 mg immunoglobulins, or combinations (200 mg/200 mg, 200 mg/800 mg).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:40.731716+00:00"}
{"study_id": 192802, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To evaluate the efficacy of bovine lactoferrin (BLF) in preventing the first episode of late-onset sepsis (LOS) in low birth weight (LBW) neonates.", "results_summary": "BLF supplementation significantly reduced the incidence of first-episode culture-proven LOS (3.2% vs. 13.4%) and sepsis-attributable mortality (0% vs. 7.5%) compared to placebo. The results were statistically significant (p\u2009=\u20090.036 and p\u2009=\u20090.027, respectively).", "population_specificity": "Low birth weight (<2000\u2009g) neonates admitted to the NICU within the first 12 hours of birth, with no maternal risk factors for sepsis.", "effective_dosage": "Increasing doses of BLF were used with higher birth weights (specific amounts not detailed in the abstract).", "study_duration": "28 days (from the 1st to the 28th day of life).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:43.055681+00:00"}
{"study_id": 192805, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize the glycosylation pattern of goat milk lactoferrin and compare it with human and bovine milk glycoproteins.", "results_summary": "The study identified 65 glycan structures in goat milk lactoferrin, with 37% sialylated and 34% fucosylated. It found similarities between human and goat milk glycans but also novel glycans unique to goat milk, suggesting potential bioactive benefits.", "population_specificity": "Not specified (focused on milk glycoprotein analysis, not human subjects).", "effective_dosage": "Not available", "study_duration": "Not applicable (laboratory study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:45.547052+00:00"}
{"study_id": 192804, "supplement_id": 1276, "safety_score": "100", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether bovine lactoferrin (BLF), alone or combined with LGG, could reduce the incidence of NEC in very-low-birth-weight neonates.", "results_summary": "BLF alone or with LGG significantly reduced NEC incidence (2.0% and 0%, respectively) compared to controls (5.4%). The combination also lowered death-and/or-NEC incidence (4.0% and 3.8% vs. 10.1% in controls).", "population_specificity": "Very-low-birth-weight neonates (<1500 g at birth) in tertiary neonatal intensive care units.", "effective_dosage": "BLF (100 mg/day) alone or with LGG (6\u00d710^9 CFU/day).", "study_duration": "From birth until day 30 of life (45 days for neonates <1000 g at birth).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:45.977636+00:00"}
{"study_id": 192788, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether lactoferrin supplementation, combined with lysozyme, could improve gut health (measured by EED biomarkers) and linear growth in children during their second year of life.", "results_summary": "The study found a modest but significant short-term improvement in gut health (\u0394%L) at 8 weeks, though the effect weakened by 16 weeks. The intervention significantly reduced hospitalization and acute malnutrition rates but did not affect linear growth.", "population_specificity": "Rural Malawian children aged 12-23 months.", "effective_dosage": "1.5 g lactoferrin and 0.2 g lysozyme daily.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:46.842198+00:00"}
{"study_id": 192806, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of camel milk, including its component lactoferrin, in managing type 1 diabetes by examining its effects on blood glucose levels, insulin dose, and beta cell function.", "results_summary": "The study suggests that camel milk, containing lactoferrin and other bioactive components, may help maintain hyperglycemia and improve diabetic management, supported by epidemiological surveys showing lower diabetes prevalence in communities consuming camel milk.", "population_specificity": "Type 1 diabetic patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:46.845778+00:00"}
{"study_id": 192809, "supplement_id": 1276, "safety_score": "95", "efficacy_score": 70, "quality_score": 85, "study_goal": "To determine the effect of bovine lactoferrin (bLF) on preventing diarrhea in children.", "results_summary": "The study found no difference in diarrhea incidence between bLF and placebo groups, but bLF reduced diarrhea longitudinal prevalence, episode duration, severity of dehydration, and liquid stool load. No adverse events related to bLF were reported.", "population_specificity": "Previously weaned children aged 12-18 months.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:48.033470+00:00"}
{"study_id": 192808, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) combination could reduce the number of colds and improve symptom recovery in individuals prone to frequent upper respiratory infections.", "results_summary": "The Lf/IgF combination significantly reduced the incidence of colds (48 vs. 112 in placebo) and the cumulative number of cold-related symptoms compared to placebo, though reductions in total days sick and cold severity were not statistically significant.", "population_specificity": "126 males and females with self-reported frequent upper respiratory tract symptoms and infections, matched by age, BMI, dietary, and physical parameters.", "effective_dosage": "600 mg daily", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:48.841402+00:00"}
{"study_id": 192807, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether exclusive feeding with fresh maternal milk (which includes lactoferrin) could prevent retinopathy of prematurity (ROP) in very low birth weight (VLBW) infants compared to formula feeding.", "results_summary": "The study found that infants fed exclusively with maternal milk had significantly lower incidences of ROP (any stage) and threshold ROP compared to formula-fed infants, with multivariate analysis confirming the protective effect of maternal milk.", "population_specificity": "Very low birth weight (VLBW) neonates in a neonatal intensive care unit (NICU) setting.", "effective_dosage": "Not specified (study focused on maternal milk vs. formula, not isolated lactoferrin dosage).", "study_duration": "Not specified (duration of feeding intervention not detailed in the abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:48.967129+00:00"}
{"study_id": 192811, "supplement_id": 1276, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine if bovine lactoferrin (bLF) supplementation could protect children aged 2-6 years against EV71 or rotavirus infection and influence serum levels of IFN-\u03b3 and IL-10.", "results_summary": "The study found no significant benefits of bLF in preventing EV71 or rotavirus infections or altering IFN-\u03b3 and IL-10 levels. No differences in infection incidence or cytokine levels were observed between the bLF and control groups.", "population_specificity": "Healthy children aged 2-6 years in a day care center.", "effective_dosage": "Approximately 70 to 85 mg/day.", "study_duration": "March 2002 to June 2003 (approximately 15 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:51.611973+00:00"}
{"study_id": 22946, "supplement_id": 1277, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of Lactosucrose (LS) on TNBS-induced colitis in rats, focusing on its potential to modulate immunity and reduce inflammation.", "results_summary": "LS supplementation ameliorated TNBS-induced colitis by increasing IL-10 production, suppressing IL-12 secretion, and reducing TLR-2 and NF-\u03baB p65 protein levels, indicating anti-inflammatory effects.", "population_specificity": "Rats with TNBS-induced colitis.", "effective_dosage": "Not specified.", "study_duration": "5 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:53.367564+00:00"}
{"study_id": 22948, "supplement_id": 1277, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of lactosucrose on intestinal microflora and its protective role against indomethacin-induced enteropathy in rats.", "results_summary": "Lactosucrose reduced the severity of small-intestinal ulcers compared to sucrose, with fewer increases in Enterobacteriaceae and streptococci, suggesting a protective effect linked to maintaining intestinal microflora.", "population_specificity": "Male Wistar rats", "effective_dosage": "Not specified (lactosucrose was fed as part of the diet)", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:54.145033+00:00"}
{"study_id": 22947, "supplement_id": 1277, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the long-term effects of lactosucrose (LS) on intestinal calcium absorption in healthy young women with lower-than-recommended calcium intakes.", "results_summary": "LS administration significantly reduced fecal pH, ammonia, and putrefactive products while increasing short-chain fatty acids (SCFA). It also improved calcium absorption and retention, as well as magnesium and phosphorus absorption, compared to placebo.", "population_specificity": "Healthy young women", "effective_dosage": "6.0 g twice daily", "study_duration": "92 weeks (with a 4-week post-administration period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:54.440970+00:00"}
{"study_id": 192812, "supplement_id": 1276, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate lactoferrin's role in bone growth, its mechanisms of action in osteoblasts and osteoclasts, and its potential as a therapeutic agent for osteoporosis.", "results_summary": "Lactoferrin promotes bone growth by stimulating osteoblast proliferation and differentiation while inhibiting osteoclastogenesis, leading to increased bone volume. It activates signaling pathways (p42/44 MAPK, PI3-kinase/Akt) and genes (IGF1, Ptgs2, Nfatc1) in osteoblasts, and dietary supplementation improves bone mineral density and strength.", "population_specificity": "Not specified (in vitro and in vivo studies mentioned, but no human population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:54.486342+00:00"}
{"study_id": 192813, "supplement_id": 1277, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of fibre intake and supplementation, including lactosucrose, during haematological cancer treatment to assess its impact on clinical outcomes and the gastrointestinal microbiome.", "results_summary": "The study identified lactosucrose as part of a combination fibre supplement used during stem cell transplantation, but specific efficacy or safety results for lactosucrose alone were not detailed. Outcomes focused on tolerability, clinical results (e.g., infection, graft versus host disease), and microbiome impact.", "population_specificity": "Patients undergoing chemotherapy, immunotherapy, or stem cell transplantation for haematological malignancy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:56.232082+00:00"}
{"study_id": 22234, "supplement_id": 1278, "safety_score": "95", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of a short-term, laughter-based intervention on mental health and cognitive functions in middle-aged adults.", "results_summary": "The study found that viewing a short comedic video significantly improved digit vigilance scores and increased cerebral blood flow in the dorsolateral prefrontal cortex, suggesting enhanced focus. It also indicated potential activation of parasympathetic activity and reduced psychological stress levels.", "population_specificity": "25 healthy Japanese-speaking adults aged 40 to 65.", "effective_dosage": "Approximately four minutes of comedic video exposure.", "study_duration": "Short-term (single session).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:56.852473+00:00"}
{"study_id": 22235, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to identify and describe gelastic (laugh-related) spells in individuals with Angelman syndrome (AS) and differentiate them from other paroxysmal events like seizures and cataplexy.", "results_summary": "The study reported three cases of gelastic syncope in individuals with AS and one case of transient breath-holding while laughing, adding gelastic syncope to the list of paroxysmal events in AS. The findings may help inform providers and parents about this phenotype and guide evaluation and treatment.", "population_specificity": "Individuals with Angelman syndrome (one child and two adults).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:57.612729+00:00"}
{"study_id": 22236, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to investigate the effects of laughter therapy on psychological (stress, anxiety, depression) and physical (pain, fatigue, sleep quality) symptoms in cancer patients.", "results_summary": "Laughter therapy effectively improved stress, anxiety, depression, pain, and fatigue in cancer patients but had no effect on sleep quality. It was described as safe, interactive, and feasible, potentially enhancing patient communication and trust in healthcare.", "population_specificity": "Cancer patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:58.924053+00:00"}
{"study_id": 22238, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of laughter yoga on nursing students' perceptions of stress and meaning of life before clinical practice.", "results_summary": "Laughter yoga significantly improved nursing students' perceived stress levels and sense of meaning and purpose in life, with statistically significant differences observed between pre- and post-test scores.", "population_specificity": "First-year nursing students (91.1% women, 97.8% single, mean age ~19 years).", "effective_dosage": "Eight sessions over four weeks (twice weekly).", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:00.865633+00:00"}
{"study_id": 22240, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize evidence on the efficacy of laughter therapy in relieving psychological symptoms (stress, depression, anxiety) in cancer patients.", "results_summary": "Meta-analysis showed laughter therapy combined with routine nursing significantly reduced stress, depression, and anxiety compared to routine nursing alone, with statistically significant results. The study concluded that laughter therapy is effective for these psychological symptoms in cancer patients.", "population_specificity": "Cancer patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:01.967151+00:00"}
{"study_id": 22239, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of laughter yoga on hope and school burnout among eighth-grade students.", "results_summary": "Laughter yoga significantly reduced school burnout scores and increased hope scores in the intervention group compared to the control group, with statistically significant differences (p < .05).", "population_specificity": "60 eighth-grade middle school students (30 intervention, 30 control).", "effective_dosage": "Twice a week for 35-40 minutes per session, totaling six sessions.", "study_duration": "Six sessions (exact total duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:02.154158+00:00"}
{"study_id": 22241, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of laughter yoga (LY) on nursing students' well-being, perceived stress, and academic self-efficacy.", "results_summary": "The intervention group showed a significant increase in well-being and a decrease in perceived stress after LY, but no statistically significant differences were found between the intervention and control groups for well-being, perceived stress, or academic self-efficacy.", "population_specificity": "Nursing students (n=83, intervention group n=41, control group n=42)", "effective_dosage": "Five sessions of laughter yoga", "study_duration": "Not specified (only the number of sessions is mentioned)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:02.285741+00:00"}
{"study_id": 22242, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of laughter therapy on perceived stress levels and quality of life in women with breast cancer receiving chemotherapy.", "results_summary": "Laughter therapy significantly reduced perceived stress and improved both physical and mental quality-of-life scores in women with breast cancer undergoing chemotherapy compared to the control group. The differences between groups were statistically significant (P < .001).", "population_specificity": "Women with breast cancer receiving chemotherapy.", "effective_dosage": "40 minutes of laughter therapy twice a week.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:03.712613+00:00"}
{"study_id": 22243, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of laughter therapy on self-efficacy and psychological well-being in nursing students.", "results_summary": "Laughter therapy increased psychological well-being scores in the experimental group, reduced stress and anxiety, improved eating and sleeping habits, and decreased social media use. However, no statistically significant differences were found in pre- and post-comparisons for all scale scores.", "population_specificity": "Nursing students (208 participants, randomized into experimental and control groups).", "effective_dosage": "Face-to-face laughter therapy once a week.", "study_duration": "Eight weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:04.336064+00:00"}
{"study_id": 22246, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of online laughter yoga on sleep quality and vasomotor symptoms in menopausal women.", "results_summary": "The laughter yoga group showed significantly reduced vasomotor symptoms and improved sleep quality compared to the control group, with statistically significant differences in posttest scores.", "population_specificity": "Menopausal women attending the Menopause School (n=36).", "effective_dosage": "Eight online laughter yoga sessions, two sessions per week.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:05.693776+00:00"}
{"study_id": 22244, "supplement_id": 1278, "safety_score": "100", "efficacy_score": 85, "quality_score": 90, "study_goal": "To assess whether laughter exercise is non-inferior to artificial tears in relieving symptoms of dry eye disease.", "results_summary": "Laughter exercise was non-inferior to artificial tears in improving ocular surface discomfort and showed better improvement in tear film stability. No adverse events were reported in either group.", "population_specificity": "Patients aged 18-45 with symptomatic dry eye disease and specific ocular surface disease index scores.", "effective_dosage": "Vocalizing specific phrases 30 times per 5-minute session, four times daily.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:05.770688+00:00"}
{"study_id": 22247, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of laughter yoga on perceived stress, job motivation, and mental well-being in intensive care nurses.", "results_summary": "Laughter yoga did not significantly change perceived stress levels or work motivation in nurses, but it showed a statistically significant (though clinically modest) improvement in mental well-being scores for the intervention group.", "population_specificity": "Nurses working in surgical and anesthesia intensive care units at a university hospital in Turkey.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:08.043415+00:00"}
{"study_id": 22248, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of laughter yoga and music intervention on depression, anxiety, and stress in elderly individuals.", "results_summary": "Both laughter yoga and music interventions significantly reduced depressive and anxiety symptoms, with laughter yoga showing superior effects and better acceptance. Stress reduction was most notable immediately post-intervention but showed some increase at follow-up.", "population_specificity": "Aged individuals (60-75 years) referred to Rafsanjan health centers with depression.", "effective_dosage": "Laughter yoga sessions twice a week for eight weeks (specific duration per session not stated).", "study_duration": "Eight weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:09.839120+00:00"}
{"study_id": 22249, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to investigate laughter-induced seizures, an extremely rare form of reflex epilepsy, and explore potential treatment strategies.", "results_summary": "The study documented a case of laughter-induced seizures in a patient with no prior medical history, finding that lifestyle modifications helped manage seizures despite normal EEG and neuroimaging results. It highlighted the lack of data on this condition and called for further research into its pathophysiology and treatment.", "population_specificity": "A single patient with no prior medical or neuropsychiatric history experiencing laughter-induced seizures.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:10.235542+00:00"}
{"study_id": 22250, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of Laughter Yoga on hemodialysis patients' quality of life and other health outcomes.", "results_summary": "Laughter Yoga showed improvements in life quality, pain severity, sleep quality, subjective well-being, mood, depression, blood pressure, and vital capacity in hemodialysis patients, though the overall effect was deemed inconclusive.", "population_specificity": "End-stage renal disease patients receiving hemodialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:10.576953+00:00"}
{"study_id": 22251, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of laughter yoga on the quality of life of cancer patients, focusing on evidence from randomized controlled trials (RCTs).", "results_summary": "Laughter yoga significantly improved the quality of life of cancer patients by enhancing emotional and physical functioning and reducing symptoms of depression and stress. The findings suggest it is a promising complementary and alternative medicine (CAM) practice for psychological and physical health in cancer patients.", "population_specificity": "Cancer patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:11.070491+00:00"}
{"study_id": 22252, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether laughter yoga could reduce test anxiety and educational stress in 8th-grade students.", "results_summary": "The study found that laughter yoga significantly decreased test anxiety and educational stress scores in the intervention group compared to the control group, with statistically significant effect sizes.", "population_specificity": "8th-grade students in Turkey (64 participants, split into intervention and control groups).", "effective_dosage": "Laughter yoga sessions twice a week.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:11.490930+00:00"}
{"study_id": 22254, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine the effect of laughter yoga on happiness and stress levels in nursing students entering clinical practice for the first time.", "results_summary": "Laughter yoga significantly increased happiness scores (p < 0.05) and reduced stress scores in the intervention group (p = 0.001), though no significant difference in stress was found between groups post-intervention (p = 0.081).", "population_specificity": "Nursing students in Turkey attending clinical practice for the first time.", "effective_dosage": "Eight laughter yoga lessons over 4 weeks.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:13.644210+00:00"}
